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ABSTRACT 
THE DISCOVERY AND EXPLORATION OF A UNIVERSAL TARGETING  
MECHANISM IN EUKARYOTIC CELLS 
 
 
 
Priyanka Sivadas, B.Tech 
 
Marquette University, 2011 
 
 
A wide range of eukaryotic organisms generate motile cilia and flagella. These 
slender organelles beat rhythmically to move the surrounding fluid or to propel cells in 
aqueous environment. Organisms use these powerful yet nimble organelles to forage, 
evade, adapt and mate. The machinery that drives this tightly controlled movement is the 
sophisticated microtubule-based axoneme. As it is critical for the survival of individual 
species, this machinery has largely been preserved to the molecular level throughout 
evolution. Proteomic studies have shown that most proteins in this biological machine 
consist of molecular modules commonly used in the cell body. But the usage of these 
modules is clearly diverged in many cases. This defined machinery with diverged 
applications provides an opportunity to understand the true capacity of the conserved 
modules. One example is the radial spoke (RS) that controls the oscillatory beating. This 
macromolecular complex contains complementary molecular modules that are 
responsible for localizing cAMP-dependent protein kinase (PKA) in the cell body. 
However, the RS does not have the features that account for the effector mechanisms of 
PKA and thus the mechanism discovered for localizing PKA has a broader role that has 
previously not been recognized. The work described in this dissertation discovered that 
the core of the RS utilizes two similar sets of PKA anchoring modules for four distinct 
effector mechanisms that underlie the assembly and function of this regulatory complex. 
These results elucidate the function of this complex and are applicable to more than 600 
diverged proteins that also share the docking module of PKA. Some of them have been 
shown to play vital roles in myriads of cellular reactions ranging from flagellar beating to 
trans-Golgi trafficking to chromosome modifications. Founded on this discovery, new 
reagents and assays were engineered. These tools could be used for the exploration of 
proteins with similar docking and anchoring modules. Together, these findings will 
accelerate the advancements in the field of anchoring and docking of proteins in the cell. 
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Chapter 1: Introduction 
 
 
1.1 Cilia and Flagella 
Cilia and flagella are hair-like organelles adopted by unicellular and multicellular 
organisms alike. Albeit differing in length and number, the fundamental structure and 
mechanism of these organelles are identical. Discoveries over the past decade have 
revealed their broad significance for a wide range of cell types and tissues. Yet the 
mechanisms related to the generation, function and maintenance of cilia and flagella are 
just emerging. Recent genomic and proteomic tools have hastened the identification of 
new proteins and molecular domains within these organelles. While some of these 
molecular domains appear to be cilia-specific, most are utilized in other cellular 
compartments as well. The proteins with these widely utilized molecular domains have 
become new targets for focused investigation. Elucidation of these key proteins and 
molecular domains will shed critical insight on these important organelles and will 
provide a solid foundation to understand and treat congenital disorders and diseases 
related to these organelles.  
 
1.1.1 The Function and Significance 
Cilia and flagella are analogous to cellular antennae, sensing environmental conditions 
for cells. Some cilia and flagella are also motile with tightly controlled rhythmic 
movement (Ishikawa and Marshall, 2011). These two main functions seem unrelated to 
each other, yet in many instances they are tightly coupled, providing cells the means to 
sense the environment and then respond accordingly. 
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The importance of these dual functional organelles has been recognized for three 
decades (Pederson and Rebbe, 1975; Afzelius, 1979 and 1981). However, the broad 
impact of the sensory function in mammals did not emerge until about 10 years ago 
(Pazour et al., 2000). As sensory organelles, the compartmentalized ciliary membrane is 
enriched with various channels (Singla and Reiter, 2006; Rohatgi et al., 2007; 
Hildebrandt et al., 2011) and vital receptors, like those for hedgehog, Patched, growth 
factors, hormones and those coupled to G proteins. For instance, in kidney, the primary 
cilium of the tubular epithelium senses the fluid flowing through the tubules using 
mechano-sensitive calcium channels. The fluid flow deforms the cilia which lead to 
opening of the channels. The calcium influx induces a cascade of signal transduction 
pathways which maintain the polarity and the homeostasis of the epithelium (Nauli et al., 
2003; Dalagiorgou et al., 2010). Defects in these cilia, whether they are ciliogenesis, 
sensing or signal transduction defects, result in dedifferentiation and unchecked mitosis 
of the tubular epithelial cells (Praetorius and Spring, 2003; Liu et al., 2005; Deane and 
Ricardo, 2007; Belibi et al., 2010). Clinically, these responses are manifested as a rather 
common disorder, polycystic kidney disease (PKD) (Pazour et al., 2000). By the same 
token, sensory cilia are pertinent to the development and maintenance of homeostasis of 
most organs (Hirokawa et al., 2009; Snell et al., 2004). Thus defects in the sensory 
function are also manifested as situs inversus, polydactyly, blindness, deafness, diabetes, 
obesity and hypertension (Lee, 2011).  
Motile cilia are important as well, albeit for different purposes. Most eukaryotic 
organisms generate motile cilia at a certain phase of their life cycle. Their distribution in 
multicellular organisms is mostly restricted to the respiratory system, ventricle of the 
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brain and reproductive organs (Baker and Beales, 2009). In the respiratory tract, motile 
cilia constantly propel mucus overlying the epithelium, along with trapped 
microorganisms, harmful compounds and irritating particulates. Ineffective mucociliary 
clearance from the respiratory tract leads to chronic respiratory infection and ultimately 
bronchiectasis and the need for a lung transplant (Lee, 2011). Motile cilia of the 
ependymal cells surrounding the ventricle of the brain circulate the cerebrospinal fluid 
(CSF). The purpose of the flow of CSF is not entirely clear. However, defects in 
ependymal cilia lead to stagnant CSF, increased ventricular pressure, hydrocephaly and 
loss of cortical neurons (Lee, 2011). During development, the cilia in the node play a 
critical role in the polarized distribution of morphogens that determine the development 
of left right asymmetry (Nonaka et al., 2002). Defects in nodal cilia result in situs 
inversus -- the internal organs are distributed in a mirror image of the normal pattern. 
Lastly, in the reproductive system motile cilia are crucial for fertility. In the female 
reproductive system, the cilia lining the fallopian tube help in the transport of the egg 
from the ovary to the uterus (Lyons et al., 2006). In the male reproductive system, a 
single flagellum propels the sperm towards the oocytes (Kaupp et al., 2008). Defective 
motility in these cilia impairs male and female fertility. Together these symptoms due to 
defective motility are referred to as primary ciliary dyskinesia (PCD) or Kartagener 
syndrome (Kartagener, 1933; Afzelius, 1976 and 1981). 
 As the motility machinery is comprised of hundreds of distinct polypeptides, PCD 
is a polygenic congenital disorder. At least 1 in 16,000 people are afflicted with PCD 
(Lee, 2011), yet the true incidence is likely to be higher since the symptoms, albeit 
diminishing the quality of life, are not life threatening. Understanding the molecular 
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mechanism of the motility machinery will provide a solid foundation for the diagnosis 
and treatment of PCD patients.   
 
1.1.2 The 9+2 Axoneme 
Regardless of the variety, all motile cilia and flagella contain a microtubule-based 
scaffold, the axoneme. Barring a few exceptions, a majority of them employ the 9+2 
format (Li et al., 2004; Hoops and Witman, 1983; Schrevel and Besse, 1975). It consists 
of nine outer microtubule doublets encircling two singlet microtubules. In contrast, the 
axoneme in immotile sensory cilia appears more primitive. Most still have 
9 outer doublets but the central pair of singlet microtubules is absent. Hence they are 
referred to as the 9+0 format. Exceptions are found in some cell types. For example, 
some motile cilia that beat with less sophisticated motion adopt 9+0 axonemes (Okada et 
al., 1999).  
In the 9+2 axoneme, the microtubule scaffold is associated with several 
distinctive molecular complexes. It is the axonemal complexes that enable these 
machines to beat with extraordinary capacity. It is not conducive to study this motility 
machinery using higher organisms because of its complicated composition and 
mechanism. Most of our current understanding of this complex machinery is derived 
from investigation of the 9+2 axoneme in the biflagellate model organism, 
Chlamydomonas reinhardtii.   
 
1.2 9+2 Machinery 
The 9+2 axoneme is highly conserved (Figure 1-1). It consists of 9 outer microtubule 
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doublets surrounding 2 microtubule singlets. Each doublet is comprised of a complete A 
tubule and a partial B tubule (Satir, 1980). The 9+2 axoneme contains all of the 
machinery and regulatory elements necessary for the controlled movement. Isolated 
axonemes, without the plasma membrane and cytoplasm, can be reactivated to beat 
rhythmically when ATP is provided (Summers and Gibbons, 1971). In addition, this 
movement is sensitive to calcium and cAMP (Kamiya and Witman, 1984). The controlled 
movement relies on the many molecular complexes associated with the 9+2 microtubule 
platform. The complexes that are easily visible in electron micrographs are best 
characterized.  
The two microtubule singlets in the center of the axoneme associate with multiple 
projections. Together these structures in the center of the axoneme are referred to as the 
central pair (CP) apparatus. Outer dynein arms (ODAs) and inner dynein arms (IDAs) 
dock to the A tubule on the outer doublet and project towards the B tubule of the 
neighboring outer doublet. Also attached to the outer doublet is the T-shaped radial spoke 
(RS). It docks to the outer doublet with a thin stalk and projects a bulbous head toward 
the CP. These axonemal structures of the 9+2 machinery appear at precise locations 
relative to each other and at exact periodicities along the length of the axoneme. When 
viewed longitudinally, four ODAs, three IDAs and two RSs are present in each 96-nm 
register (Warner and Satir, 1974; Mastronarde et al., 1992, Nicastro et al., 2005, 2006). 
Each projection has a distinct role but they operate in concert to generate oscillatory 
beating. 
It is well established that oscillatory beating of motile cilia and flagella is founded 
on the inter-doublet sliding driven by dynein motors (Summer and Gibbons, 1971). ATP 
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hydrolysis in the motor head induces conformational changes, leading to a power stroke. 
The motor walks against the neighboring outer doublet towards the minus end, i.e. the tip 
of the flagella. This conversion of chemical energy into physical force by the dynein 
motor triggers the sliding between adjacent outer doublets (Lindemann and Lesich, 
2010). The static linkers like nexin between outer doublets convert this sliding into bend 
formation. In theory, alternate sliding of opposing outer doublets is the foundation of 
oscillatory beating (Smith and Yang, 2004). 
In contrast to the well characterized dynein motors and the dynein-driven sliding, 
the control of this sliding is not well understood.  
 
1.3 Proposed Roles of RS and CP 
It is apparent that the thousands of dynein motors distributed in each of the 9 outer 
doublets and along the length of the axoneme must take turns undergoing the power 
stroke in order to alternate inter-doublet sliding, generate bends and thus oscillatory 
beating. If all of the motors became activated simultaneously, there would be no net 
movement and the flagella would become paralyzed. Such paralysis has been observed in 
Chlamydomonas mutants as well as human patients, due to deficiencies in the RS or the 
CP (Witman et al., 1978; Zariwala et al., 2007; Castleman et al., 2009). Independent lines 
of evidence suggest that the RS and the CP constitute a system that determines which  
subsets of motors become activated and which sets of outer doublets undergo sliding.  
Studies of suppressor mutations of the paralyzed RS and CP mutants have found 
that mutations in dynein motors and a group of 6 proteins adjacent to the motors can 
partially rescue the paralysis of RS and CP mutants without restoring either structure. 
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Figure 1-1. Cross sectional view of 9+2 axoneme. 
 
(A) Electron microscopy of Chlamydomonas axoneme and (B) the schematic 
representation. The scale bar represents 100 nm. 
A 
B 
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Therefore, these 6 proteins were referred to as the dynein regulatory complex (DRC) 
(Huang et al., 1982; Porter et al., 1994; Piperno et al., 1992, 1994). These results led to a 
well-accepted model that the RS and the CP constitute a system to control dyneins 
through the DRC. In theory, without the RS or the CP, dyneins are inhibited and 
suppressor mutations in the dynein motors and DRC bypass this inhibition and restore the 
motility.  
Despite the paralysis of the RS and CP mutants, these two prominent features in 
the 9+2 axonemes are not required for motility. Certain cilia, like nodal cilia are motile 
inspite of their 9+0 axonemal arrangement (Nonaka et al., 1998). These cilia beat with a 
very shallow waveform and at a low frequency, contrary to the planar waveform and high 
frequency beating characteristic of 9+2 axonemes (Okada et al., 1999). Similarly, the 
suppressor mutants exhibit a symmetric flagellar waveform unlike the asymmetric 
waveform of wild-type cells (Omoto et al., 1996; Brokaw et al., 1982). Thus it was 
postulated that the RS/CP control system overrides the rudimentary machinery, primarily 
composed of 9+0 outer doublets and motors (Kamiya, 2002) and confers the high 
frequency, asymmetric waveform characteristic of most cilia and flagella. This 
dissertation investigates molecular interactions that underlie the assembly and the 
mechanism of the RS. 
 
1.4 The Radial Spoke 
1.4.1 Radial spoke: The Mechanochemical Signal Transducer 
The radial spoke is in position to directly activate dynein motors. The base of the RS is 
near IDAs. Furthermore, electron microscopy of cilia that were instantaneously fixed 
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while beating showed that the radial spoke is a mobile element similar to dynein motors 
and the CP. It undergoes cycles of attachment and detachment with the CP. This 
conclusion was founded on the observation that the RSs at the bend of the flagella tilt and 
lengthen slightly (Warner and Satir, 1974; Goodenough and Heuser, 1985; Curry and 
Rosenbaum, 1993). Also, in most motile cilia, during oscillatory beating the central pair 
apparatus rotates once per beat (Tamm and Tamm, 1981; Omoto et al., 1999). It was 
postulated that the tensio0n or force experienced by the RS from the rotating central pair 
and sliding outer doublets activates subsets of dynein motors (Omoto et al., 1999).  
The radial spoke is also implicated in the modulation of oscillatory beating. The 
beating of all cilia and flagella is sensitive to common second messengers like calcium 
and cNMP (Smith and Yang, 2004). These second messengers induce changes in the 
beating partly through phosphorylation (Tash et al., 1989). For instance, calcium 
concentrations affect the flagellar waveform. At 10-8 M calcium, the reactivated 
axonemes beat with a highly asymmetric waveform which allows the cells to swim 
forward. When the concentration increases to 10-4 M, the movement switches from 
asymmetric to symmetric waveform, enabling cells to swim backward (Bessen et al., 
1980; Kamiya and Witman, 1984). As the suppressor of RS mutant exhibits symmetric 
flagellar waveform, it was proposed that the RS is required for the generation of 
asymmetric waveform at low calcium concentrations (Brokaw et al., 1982). A study 
using microtubule-sliding of axonemes from the RS mutants also implicates the RS in 
calcium-induced changes in motility (Smith, 2002).   
In addition, it was proposed that dynein activity is inhibited by kinases and the RS 
in the WT axoneme operates to inhibit the kinases. While the flagella lacking the RS are 
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paralyzed, the axonemes can still undergo sliding. However, the sliding velocity is 
reduced to half that of the WT flagella. The sliding velocity was restored to WT levels if 
inhibitors for cAMP-dependent protein kinases and casein kinases were present (Howard 
et al., 1994; Yang and Sale, 2000). On the other hand, inhibitors for phosphatases, PP1 
and PP2A reversed the effects of the kinase inhibitors (Habermacher et al., 1996; King 
and Dutcher, 1997; Yang and Sale, 2000). Thus it was proposed that the kinases inhibit 
dynein motors and the RS operates to eliminate this inhibition.    
Together, the evidence from genetic and functional studies supports a model that 
the radial spoke regulates flagellar beating as a mechanochemical signal transducer.  
 
1.4.2 Radial Spoke Composition 
The composition of the RS was first revealed indirectly by the studies of Chlamydomonas 
mutants. Electron microscopy shows that the flagella of pf14 mutants lack the entire RS 
complex (Witman et al., 1978). The compositional analysis demonstrated that the 
morphological phenotype correlated with the absence of 17 proteins. Thus it was 
concluded that the T-shaped complex is composed of at least these 17 polypeptides, 
referred to as radial spoke proteins (RSPs) (Piperno et al., 1977, 1981) (Figure 1-2). 
Using dikaryon cytoplasmic complementation and revertant mutagenesis, it was found 
that the phenotype is caused by a mutation in the RSP3 gene. Comparison of RSPs in the 
axonemes from the spoke-less mutants and the mutants lacking only part of the RS 
predicts that the bulbous spoke head consists of five proteins (RSP1, 4, 6, 9 and 10). The 
rest of the proteins are proposed to be located in the spoke stalk (Piperno et al., 1977; 
Huang et al., 1981). Based on the RSP2 mutant pf24, the stalk proteins, RSP2, RSP16 
11 
 
 
and RSP23 are predicted to be located underneath the spoke head in a subcomplex 
referred to as the spoke neck complex. In the pf24 axoneme, RSP2, RSP16, RSP23 and 
spoke head proteins are less abundant, while the remaining spoke stalk proteins appear 
normal (Huang et al., 1981; Patel-King et al., 2004; Curry and Rosenbaum, 1993). These 
predictions are further supported by selected loss of RSPs by low salt dialysis (Piperno et 
al., 1981) and by chemical crosslinking (Kohno et al., 2011). This arrangement is related 
to the questions addressed in this dissertation. 
Consistent with the genetic evidence, the 17 RSPs are present in an isolated radial 
spoke that sediments as a 20S particle in a sucrose gradient. The 20S RS also contains 5 
more molecules. Among the five, three molecules, IP2,3 and 4, form a complex that 
associates with the RS and may be involved in anchoring the RS to the outer doublets 
(Dymek et al., 2007; 2011). The other two are LC8 and calmodulin, the calcium sensor 
(Yang et al., 2001; Patel-King et al., 2004). This finding supports the notion that the 
radial spoke is involved in calcium induced motility changes. As these two molecules are 
present in multiple axonemal complexes, they were not absent from the spoke mutants, 
they were only recognized as RSPs following purifications of the RS.  
Through multiple independent approaches, the genes encoding most molecules 
were identified.  Their amino acid sequences and predicted molecular domainss were 
determined (Williams et al., 1989; Curry et al., 1992; Patel-King et al., 2004; Yang et al., 
2004; Yang and Yang, 2006; Yang et al., 2006; Dymek et al., 2007). Interestingly, 
molecular modules related to signal transduction are located exclusively in the 
spokestalk, while the spokehead primarily consists of structural proteins. In particular, 
two stalk proteins, RSP7 and RSP11 contain a RIIa domain that is also present in PKA. 
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Curiously, two molecules, RSP2 and RSP23 contain a Dpy-30 domain that resembles the 
RIIa domain. In addition, these four molecules also contain calcium-binding motifs and 
calmodulin-binding domains (Yang et al., 2006). This dissertation study reports the 
discovery that RSP3 is the key molecule that integrates these RSPs with distinctive 
molecular modules. 
 
1.4.3 RSP3 
1.4.3.1 RSP3: Sequence and Homology 
Independent lines of evidence have shown that RSP3 plays multiple roles in the RS. One 
striking feature of RSP3 is its sequence homology. RSP3 orthologues from various 
organisms, ranging from Chlamydomonas to humans, share a higher homology than most 
components unique to axonemes (Gaillard et al., 2001). All RSP3 orthologues contain the 
highly conserved N terminal 320-a.a. (amino acid) region. Chlamydomonas RSP3 has an 
additional ~200 a.a at the C-terminus, while a mammalian alternative-spliced isoform has 
a ~100 a.a. extension at the N-terminus (Jivan et al., 2009). This high sequence homology 
of the 320 a.a. residues implies a strong evolutionary pressure to maintain a key function. 
 
1.4.3.2 RSP3 Docks the RS to the Axoneme 
RSP3 is essential for the assembly of the RS (Luck et al., 1977; Piperno et al., 1981). The 
RSP3 gene in the pf14 mutant has a premature stop codon near the translation initiation 
site. Translation initiated from a downstream ATG produces diminished amounts of 
truncated RSP3 polypeptides that fail to assemble into the axoneme (Williams et al.,  
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HEAD 
NECK 
BASE 
STALK 
Figure 1-2. Radial spoke proteins and their predicted functional domains. 
 
The radial spoke proteins are arranged based on their predicted locations. The Dpy-30 
domain and RIIa domains are highlighted in red and green boxes respectively. MN, 
MORN domain; DPY, Dpy-30 domain; GAF, cyclic GMP Adenylyl cyclase FhlA 
domain; CAM, calmodulin binding motif; AKAP, A-Kinase Anchoring Protein; IQ, 
calmodulin binding motif; NDK, Nucleoside Diphosphate Kinase domain; DnaJ and 
DnaJ-C, molecular chaperone homology domains; RIIa, RII alpha domain; EFH, EF-hand 
domain; PPI, Peptidyl Prolyl Isomerase domain; LRR, Leucine Rich Repeat domain. 
Coiled coil regions are depicted by open bars. This figure was modified from Yang et al., 
2006. 
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Table 1-1. Chlamydomonas radial spoke mutants that are relevant to this 
dissertation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutants Motility phenotype 
Morphological 
Defect 
Gene 
product 
Protein 
missing 
RSPs in 
reduced amount 
Predicted 
location 
pf14 Paralyzed Spokeless RSP3 All spoke proteins NA Base 
pf24 Paralyzed Less spokeheads 
and stalks RSP2 None 1,4,6,9,10,2,16,23 Neck 
pf25 Swimming/Paralyzed None RSP11 11 8 Base 
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1989), leading to spoke-less axonemes in pf14. The importance of the N-terminus is 
clarified by a reconstitution experiment. Reconstitution of axonemes and recombinant 
RSP3 synthesized in rabbit reticulocyte lysate showed that RSP3 binds to the axoneme. 
The binding site is confined to the N-terminal 85 a.a.. In parallel, expression of truncated 
RSP3 from a cDNA minigene construct also showed that the N-terminus of RSP3 is 
required for rescuing the motility of pf14 while the C-terminus is dispensable (Diener et 
al., 1993). Based on these results from in vitro and in vivo experiments, it was proposed 
that RSP3 is located at the base of the RS for anchoring the entire RS to outer doublets. 
The function of the rest of the conserved region is unknown.  
 
1.4.3.3 RSP3: A Homodimer 
Chemical crosslinking of isolated axonemes showed that RSP3 exists as a homodimer in 
the RS. The axoneme-binding region is capable of dimerization (Wirschell et al., 2008). 
It is speculated that this stable homodimer forms the scaffold at the base of the RS onto 
which other RSPs assemble. The results from this dissertation show that the dimeric 
RSP3 is a scaffold extending throughout the RS, not just at the base, which directly 
interacts with key RSPs. 
 
1.4.3.4 RSP3: The Spoke AKAP 
RSP3 is currently referred to as an A-kinase anchoring protein (AKAP). From a historic 
perspective, the key role of AKAPs is to anchor the cAMP dependent protein kinase 
(PKA) (Pidoux and Tasken, 2010). PKA is a tetrameric holoenzyme with two catalytic 
subunits and two regulatory subunits, RI or RII (Figure 1-3). It is the primary effector for 
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the cAMP signal transduction pathways (Logue and Scott, 2010). Like the ubiquitous 
second messenger, cAMP, many AKAPs have been identified in various intracellular 
compartments. They differ drastically in their size and sequence. Yet they all have 
several common properties (Welch et al., 2010) (Figure 1-3). First of all, they all contain 
a ~14-18 a.a. amphipathic helix (AH) that interacts with the 40-a.a. dimerization and 
docking domain (D/D), RIIa, in the regulatory subunit, either RI or RII isotypes of PKA 
(Carr et al., 1991) (Figure 1-3 and 1-4). It is this very interaction that localizes PKA. In 
addition, all AKAPs contain a site that binds to a particular intracellular compartment, 
such as the cytoskeleton, mitochondria or Golgi (Wong and Scott, 2004). Lastly, they 
also contain additional motifs for binding to various molecules critical for different signal 
transduction pathways such as phosphatases and other kinases (Klauck et al., 1996; 
Welch et al., 2010). Thus it was proposed that AKAPs localize this enzyme of broad 
substrate specificity near its intended target proteins. The binding of cAMP to the 
regulatory subunit leads to the release and activation of the catalytic subunits which in 
turn phosphorylate the adjacent substrate (Figure 1-3). Presumably the anchoring of PKA 
through AKAPs improves the precision and efficiency of cAMP mediated signal 
transduction (Scott and Pawson, 2009). Furthermore, by anchoring PKA along with other 
molecular switches which may be synergistic or antagonistic, the different signal 
transduction pathways can be integrated (Figure 1-4 A). 
Initially, anchoring proteins of PKA were identified based on their co-purification with 
PKA (Lohmann et al., 1984; Vallee et al., 1981). The interaction was mapped to the RIIa 
domain in the regulatory subunit (Scott et al, 1990) and an AH in AKAPs (Carr et al.,  
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Figure 1-3. The tetrameric holoenzyme of cAMP-dependent protein kinase. 
 
(A) The functional domains in the regulatory and catalytic subunits of PKA. The 
regulatory subunit contains an N terminal docking and dimerization domain 
known as the RIIa domain; two cAMP-binding sites and an auto-inhibitory site 
that binds the catalytic subunit and blocks catalysis. The catalytic subunit contains 
an ATP binding site, a substrate binding site and a regulatory subunit binding site. 
(B) The mechanism of PKA. The PKA tetramer contains two regulatory subunits 
(grey boxes) and two catalytic subunits (blue circles). The holoenzyme is inactive 
until cAMP (orange circles) occupies the cAMP binding sites in the regulatory 
subunit. This releases the active catalytic subunits (red circles) which 
phosphorylate the substrates. 
 
A 
B 
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A 
B 
Figure 1-4. AKAPs: The signaling scaffolds and their interaction with the RIIa 
domain. 
 
(A) Schematic showing three main features of an AKAP: a targeting domain that 
anchors an AKAP to a specific subcellular location; an amphipathic helix (yellow) that 
binds to the RIIa domain of PKA (pink and purple) and additional sites that binds 
other signaling molecules. RII, regulatory subunit; C, catalytic subunit. (B) Crystal 
structure of RIIa domain (blue and pink helices in complex with AKAP (yellow). This 
structure is modified from PDB ID: 2IZY (Gold et al., 2006). 
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1991). Most AKAPs were identified using an overlay using radioactive RII as a ligand 
(Lohmann et al., 1984). This assay was used to screen expression libraries or protein  
blots. The binding is blocked by AHs with high affinities for the dimeric RIIa (Carr et al., 
1992; Alto et al., 2003; Burns-Hamuro et al., 2003). Many proteins were found to bind 
RII in vitro, and thus they were referred to as AKAPs and presumed to anchor PKA in 
vivo. The micro-compartments that they are located in are presumed to be regulated by 
PKA. Similarly, the RI regulatory subunit of PKA is also used in overlays. Based on the 
affinity and specificity of AKAPs for RI or RII, AKAPs are classified into three 
categories, RI-AKAP that interacts with RI alone; RII-AKAP that interacts with RII 
alone; and dual AKAP (D-AKAP) that interacts with both RI and RII.  
 
1.5 The RIIa Clan 
While the AH-RIIa interaction was exploited to identify the PKA anchoring proteins, 
AKAPs, the RIIa domain has been found in many proteins that are irrelevant to PKA. In 
fact, this domain is present in more than 200 molecules with diverged molecular 
architectures in various eukaryotic genomes. Most of them are poorly characterized. Two 
such molecules are in the radial spoke complex of Chlamydomonas flagella, RSP7 and 
RSP11 (Yang and Yang, 2006; Yang et al., 2006). Furthermore, a RIIa-like domain, Dpy-
30, was found in equally numerous poorly characterized molecules, including two 
proteins in the radial spoke complex, RSP2 and RSP23 (Yang et al., 2006). These 
proteins with either a RIIa or Dpy-30 domain are classified into two subfamilies within 
the RIIa clan in the protein family database Pfam (Table 1-2). 
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1.5.1 RIIa Clan Domains  
RIIa and Dpy-30 domains share considerable similarities in sequence, secondary 
structure and tertiary structure. However, they also have significant distinctions that 
define the two domains. 
 
1.5.1.1 RIIa Domain 
The RIIa domain is usually 40-a.a. long. RIIa domains share extensive sequence 
homology, except the N-terminal region. The core is comprised of a helix-loop-helix 
secondary structure (Newlon et al., 1999 and 2001). Structural studies have primarily 
focused on RII’s RIIa domain. The structures showed that two helix-loop-helix 
monomers fold into a X-type four helix bundle (Gold et al., 2006; Kinderman et al., 
2006) (Figure 1-4). The dimerization forms a shallow groove that binds to the AH in 
various AKAPs. The lateral boundary was defined by a β-strand from the N-terminus 
(Kinderman et al., 2006).   
The interaction of the dimeric RIIa and the AH is primarily hydrophobic in 
nature. The hydrophobic residues in the groove of the RIIa dimer, including the β-strand, 
associate with the hydrophobic residues clustered on one side of the amphipathic helix.  
More recent structures of RI’s RIIa domain in complex with an AH also revealed a 
similar X-type four-helix bundle (Banky et al., 2003; Sarma et al., 2010). However, the 
N-terminus unique to RI’s RIIa is helical, contrary to the β-strand in RII’s RIIa. The 
additional helix folds inwards, resulting in a much deeper hydrophobic, AH-binding 
cavity (Banky et al., 2003; Sarma et al., 2010). 
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1.5.1.2 Dpy-30 Domain 
In contrast to the RIIa domain, the study of the Dpy-30 domain is relatively nascent. 
Dpy-30 in C.elegans was the first Dpy-30-domain containing protein discovered. The 
name was derived from the dumpy phenotype of the mutant nematode defective in the 
encoded gene. Genetic analyses revealed that the protein is part of the chromosome 
modification complex. It not only affects the body shape but is also involved in X- 
chromosome dosage compensation (Hsu et al., 1994). Studies in other organisms revealed 
that the Dpy-30 protein is also a small yet critical subunit in various Set1- like histone 
methyltransferase complexes that mediate epigenetic regulation in most eukaryotic cells 
(Roguev et al., 2001; Cho et al., 2007; Patel et al., 2009). In embryonic stem cells, 
depletion of Dpy-30 blocks the neuronal differentiation (Jiang et al., 2011). A 40-a.a 
region in this ~100-a.a. Dpy-30 ortholog shares limited sequence homology with the RIIa 
domain in PKA (Roguev et al., 2001). As more genome sequencing projects were 
completed, sequences with homology to this region were found in many divergent 
proteins. The sequences associated with this conserved domain vary drastically. Thus this 
conserved motif was named the Dpy-30 domain.  
Analogous to the RIIa domain, this new domain is also composed of a helix-loop-helix 
secondary structure. However, this common unit in all Dpy-30 domains is preceded by a 
short helical sequence that is absent in RII’s RIIa domain (Wang et al., 2009) (Figure 1-
4). The recently solved X-ray crystal structure of this domain from the human Dpy-30 
protein also forms an X-type four-helix bundle. The N-terminal helix occupies the 
position of the β-strand in RII’s RIIa domain. The cavity in the dimer is deeper and less 
hydrophobic than RII’s RIIa domain (Wang et al., 2009). Numerous AHs that bind the  
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Table 1-2. The RIIa-clan members 
 
The RIIa clan consists of two subfamilies, RIIa and Dpy-30. The RIIa clan 
domain containing proteins listed above are classified based on the functional 
modules associated with the RIIa clan domain. RIIa, RII alpha domain; GK, 
Guanylate Kinase domain; ADK, Adenosine Diphosphate Kinase domain; 
NDK, Nucleoside Diphosphate Kinase domain; Dpy-30, Dpy-30 domain; IQ, 
calmodulin binding motifs; EF, calcium binding EF hands; cNMP, catalytic 
subunit of proteins kinase A; CaMB, calmodulin binding motif. 
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Figure 1-5. Crystal structures of the RIIa clan domains. 
 
(A) The RIIa domain from RII (PDB ID: 2HWN, Gold et al., 2006) and (B) the 
Dpy-30 domain from the human Dpy-30 protein (PDB ID: 3G36, Wang et al., 
2009). 
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RIIa domain have been discovered and two sequences in Ash2 of the histone 
methyltransferase complex and BIG1 GTPase exchange factor in the Golgi apparatus 
were found to bind Dpy-30 protein during the period of this thesis (South et al., 2010; Xia 
et al., 2010). The common feature among Dpy-30 binding sequences remains uncertain. 
The similarity of these D/D domains and the numerous proteins with these 
domains begs an important question about the specificity. How do these similar domains 
dock these important proteins to the appropriate locations: PKA to the cAMP-signaling 
sites, Dpy-30 to the histone methyltransferase complex and BIG1 GTPase exchange 
factor to the Golgi? What are the other functions that these similar D/D domains may 
dock? 
 
1.5.1.3 RII- Clan-Domain Containing RSPs 
These questions can be elucidated by investigating the RS. The RS contains an AKAP 
that binds PKA’s RII in vitro (Gaillard et al., 2001). Instead of PKA, the RS also harbors 
four non-PKA RIIa clan members. RSP7 and RSP11 have RIIa domains; and RSP2 and 
RSP23 have Dpy-30 domains (Yang et al., 2006). All four proteins are in the stalk.  
Consistent with the docking function of the domains, genetic evidence suggests that the 
paired RIIa-containing RSPs and Dpy-30-containing RSPs are located at opposite ends of 
the stalk. It is unclear how these four molecules with a similar D/D domain dock onto the 
different parts of the small RS complex and contribute to its role in mechanochemical 
regulation. 
The RSP2 mutant, pf24, generates paralyzed flagella due to an initiation codon 
mutation in the gene encoding RSP2 (Huang et al., 1981; Yang et al., 2004). The 
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axoneme has diminished amounts of RSP2 protein, the spoke HSP40 and Dpy-30-
containing RSP—RSP23, while the spokehead components are reduced, albeit less 
drastically (Huang et al, 1981; Patel-King et al., 2004). Thus it was predicted that Dpy-30 
domain containing RSP2 and RSP23 are co-assembled along with RSP16 near the neck. 
Note that the deficiency of the spoke head is less severe than that of RSP2, indicating that 
RSP2 is only one of the molecules linking the spoke head to the spoke stalk.   
It was recently shown that the assembly of RSP2 to the RS is mediated by the 
Dpy-30 domain and the trailing coiled coil. The calmodulin binding motifs within the C 
terminal region of RSP2 also suggest that RSP2 is involved in regulating flagellar beating 
(Gopal et al., unpublished). The additional sequence in RSP23 contains a NDK domain 
that converts NDP to NTP. Consistent with this, the RS contributes to a fraction of the 
NDK activity in the axoneme. The role of this NDK domain remains to be determined.  
The two RIIa-containing RSPs appear normal in the pf24 axoneme and thus they 
are predicted to be located away from the neck region. The sequences tethered to the RIIa 
domain are equally intriguing. A series of calcium-binding EF hands trail the RIIa 
domain in RSP7. The additional sequence in RSP11 is devoid of any molecular domains. 
RSP11 is not essential for the assembly of the RS or for motility (Yang and Yang, 2006). 
Mutants lacking RSP11 generates motile flagella only when the media is fresh and 
enriched. The flagella become paralyzed when the media is exhausted of nutrients in the 
stationary phase. The mutant also displays reduced levels of RSP8, another RS subunit 
with armadillo (ARM) repeats known for protein-protein interactions (Yang et al., 2006).  
This suggests that RSP8 and RSP11 interact. However, the nature of the association of 
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these two proteins and why deficiencies in these two proteins result in reversible 
paralysis is unclear.  
Although RII, RSP7 and RSP11 all have the RIIa domain, mutations of the AH in 
RSP3 abolished only the interaction of RSP3 with RII in the overlay assay (Gaillard et 
al., 2006). The same mutation when introduced into Chlamydomonas, caused a mixed 
population of swimmers and immotile cells (Gaillard et al., 2006) but the amount of the 
RIIa-domain containing proteins, RSP7 and RSP11, was not reduced (Gaillard et al., 
2006). These inconsistencies raise several questions. Does the amphipathic helix serve to 
anchor PKA to the RS; or the non-PKA RIIa-containing RSP7 and RSP11? If it does 
anchor these two RSPs, why are they still assembled when the amphipathic helix is 
perturbed? What molecules do the Dpy-30 domain in RSP2 and RSP23 interact with and 
what are their sequences? The answers to these questions will reveal the topology of the 
RS and help to understand how RS regulates flagellar beating mechanically and 
chemically. Importantly, the answers could elucidate the mechanisms that distinguish the 
specificity of these two similar RIIa clan domains and the effector mechanisms that tether 
to these putative D/D domains. 
 
1.6 Objectives of the Research 
Objective 1: Test the hypothesis that the spoke AKAP, RSP3, forms the backbone of 
the radial spoke stalk. 
We reason that the arrangement of the four RSPs with the RIIa clan domains must 
provide the predicted rigidity necessary for RS to couple the mobile CP and the outer 
doublets at high frequency (Warner and Satir, 1974). The simplest model is that all four 
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molecules anchor to the dimeric RSP3. As RSP2 and RSP23 are located near the 
spokehead and the RSP3 N-terminus binds to the axoneme, this prediction implies that 
RSP3 forms the spoke scaffold, extending throughout the RS complex. Chapter 3 is 
focused on testing this hypothesis. To test this hypothesis, truncations were made within 
RSP3. The flagella of the mutant strains were analyzed for their composition and 
morphology. We predict that deleting the binding sites for the RIIa domain or for the 
Dpy-30 domain shall result in deficiencies in the four RSPs, either in their composition or 
their stability. Electron microscopy studies on some of these mutants showed that 
truncating RSP3 results in a dwarfed radial spoke stalk which is consistent with RSP3 
forming the RS scaffold. This work is described in Section I of Chapter 3. 
Objective 2: Identify the binding sites for the RIIa domain and the Dpy-30 domain 
in the RS 
Once the binding proteins and the binding regions were identified in vivo, an in vitro 
approach was taken to define the binding sequence. The binding sequence and the D/D 
domains were co-expressed in bacteria for testing their interaction by co-purification. 
Once the binding sequence for the Dpy-30 domain was identified, sequence analyses 
were conducted to determine the similarity and distinction of the binding sequences for 
the RIIa and the Dpy-30 domains. This work is described in Section II of Chapter 3. 
Objective 3: Develop tools to study the RIIa domains and Dpy-30 domains. 
The study of Dpy-30 domains is still emerging. Many Dpy-30 domain containing 
proteins and their anchoring proteins are poorly characterized.  Even the Dpy-30 domain 
in the Dpy-30 protein, is known to anchor at least two molecules, Ash2 in the histone 
methyltransferase complex and BIG1 in the Golgi apparatus (South et al, 2010; Xia et al., 
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2010). It is likely that more Dpy-30-anchoring proteins remain to be discovered. In 
addition, the similarity of the anchoring sequences discovered in this dissertation raises 
question about the distinction in the specificity, affinity and kinetics of the two types of 
D/D domains. This dissertation developed alternative reagents and assays to address these 
questions. This project is described in Chapter 4. 
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Chapter 2: Materials and Methods 
 
The chemicals, biological reagents, molecular biology, cell biology and protein 
biochemistry methods used in this study are outlined in this chapter. 
 
2.1 Materials 
2.1.1 Chemical Reagents 
Chemical reagents used in this study are summarized in Table 2-1. 
2.1.2 Oligonucleotides 
Oligonucleotides used in this study for polymerase chain reactions (PCR) to engineer 
plasmids and truncation mutants are listed in Table 2-2. 
2.1.3 Antibodies 
The antibodies used in this study are listed in Table 2-3. 
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Table 2-1. Chemicals used in this study 
Vendor Name 
Amresco Yeast Extract 
Dithiothreitol (DTT) 
Isopropyl-β-D-thio-galactoside (IPTG) 
Bio-Rad Acrylamide 
Biolab Inc. dNTPs 
Calbiochem Nonidet-P40 
Celliance Aprotinin 
EM Sciences Osmium Tetroxide 
Propylene oxide 
2,4,6-(Tri(Dimethylaminoethyl)phenol) (DMP30) 
Dodecenyl succinic anhydride (DDSA) 
Nadic methyl anhydride (NMA) 
EMBed-812 
Uranyl Acetate 
Invitrogen Urea 
JT Baker Methanol 
Potassium hydrogen phosphate (K2HPO4) 
Potassium dihydrogen phosphate (KH2PO4) 
Tris Base 
 Fisher Scientific Potassium iodide 
Mallinckrodt Sucrose 
Midwest Sci. Agarose 
Tryptone 
MP Biomedicals Paromomycin 
Polysci Inc. Sodium Cacodylic acid 
Shelton Scientific Bromophenol blue 
 Spectrum Chemical Dibucaine 
Stratagene Pfu DNA polymerase 
TCI America Luminol 
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Sigma Acetic acid 
Agar 
Ammonium chloride (NH4Cl) 
Ammonium persulfate 
Ammonium nitrate (NH4NO3) 
Boric acid (H3BO3) 
Bovine Serum Albumin (BSA) 
Calcium Chloride dehydrate (CaCl2.2H2O) 
Cobalt Chloride hexahydrate (CoCl2.6H2O) 
Coumaric acid 
Cupric sulfate pentahydrate (CuSO4.5H2O) 
 L-Cysteine 
Ammonium heptamolybdate ((NH4)6Mo7O24) 
Dimethyl Sulfoxide (DMSO) 
Ethidium Bromide 
Ethylenediaminetetraacetic acid (EDTA) 
Ethylene glycol tetraacetic acid (EGTA) 
Ferrous sulfate (FeSO4.7H2O) 
Glycerol 
Glycine 
Glutaraldehyde 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes) 
Hydrogen peroxide (H2O2) 
Imidazole 
Kanamycin 
β-mercaptoethanol 
Manganese sulfate (MnSO4) 
Manganese chloride (MnCl2) 
Magnesium sulfate heptahydrate (MgSO4.7H2O) 
Phenylmethanesulfonyl fluoride (PMSF) 
Polyethylene glycol (PEG 8000) 
Ponceau S 
Potassium Acetate (KCH3COO) 
Potassium chloride 
Ribonuclease 
Sodium Dodecyl Sulfate 
Sodium chloride (NaCl) 
Sodium Hydroxide (NaOH) 
Sodium Acetate (NaCH3COO) 
Sodium Carbonate (Na2CO3) 
Sodium phosphate (NaH2PO4) 
Sulfosalicylic Acid 
Tannic acid 
Tetramethylethylenediamine (TEMED) 
Zinc sulfate heptahydrate (ZnSO4.7H2O) 
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Table 2-2. Oligonucleotides used in this study 
 
Name Sequence 
XbaS AGCTCTAGACTACTCTCAGCTTGAGCCACATTTATGC 
XhoAS TCTCCATCAGGCCCTGCTCGAGCACCTTGCCCAC 
XhoS TCTCGAGCTGTCTGGCATTGTCAACACGGTG 
AS TCTTGTCCGCCTCCCACTTGGCGTTG 
SpeS CCGCAAGCTCACTCGTTCACCATAAAC 
NotAS AGCGGCCGCGCGATTGGCTGCCAGCGCCGCCGC 
EcoRIS GGAATTCCCGCTCTGCTCTCCAGTCCGACTAGGG 
XbaAS1 GCTCTAGACGCCAGGGTGCTGCGATTGGCTGCC 
XbaAS2 GCTCTAGAGCCGCGCGCAAAGGCGCTGGCCGCC 
XbaAS3 GCTCTAGACTCCTCCTCCTCCAGCACCTCCATCAGG 
XbaS(tag) GCTCTAGACAGGCGCTGGCGGTGCACGCGCTGGG 
EcoRIAS GGAATTCTGTTGCCTGAGAGCTCCGCCTCGGCC 
XhoS ACCTCGAGCACCACCACCACCACCACTAAGCTAGAGGG 
ICAS ACCTCGAGGGGGTACGTAGATGTAGCCGCT 
96BamS GCGGATCCCGGCACATCGACATCCAAACGGAC 
180RIAS CGGAATTCTTACTCCTCCAGCACCTCCATCAGGC 
245BamS GCGGATCCGCCTTTGCGCGCGGCTACCTGTCTGGC 
316RIAS GCGAATTCGGTGCTGCGATTGGCTGCCAGCGCCGC 
269BamS GCGGATCCCCCGTCATGCGCGAGGTGGAGACGG 
NdeS CCCATATGGAGCCAGAGCAGATGCTGGAG 
DpyHindAS GCAAGCTTCTGGAGATCTACCTTCTGCTTTGATGAC 
RSP2HindS GCAAGCTTCCCGACACAGCCTACCTCAAAGAGAC 
RSP2XhoAS GCCTCGAGTCATTCTACTTCAGCATTTTTCACGTATTTGAGC 
PstIS GCTGCAGAAGGTAGATCTCCAGTCTTTGCCAAC 
NheIAS GGCTAGCTCAGTTTCGATCTTCAAACTGTGCC 
NcoS GCCCATGGAGTCCCCTATACTAGGTTATTGG 
GSTAS GGGGGATCCACGCGGAACCAGATCCG 
280BamS GCGGATCCCCCTGGCTCAAGGAGCAGG 
306RIAS GCGAATTCGTCCTCCACCAGCTTGTCCACC 
298RIAS GCGAATTCGCGCCGCGCCACCAC 
308RIAS GCGAATTCCGCCGCGTCCTCCACCAGCTTGTCC 
HybridS GATCTGGTTCCGCGTGGATCCCCCTGGCTCAAGGAGC 
V*PS GTGGCGCGGCGCGTGCCGGACAAGCTGGTGGAG 
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V*PAS CTCCACCAGCTTGTCCGGCACGCGCCGCGCCAC 
H301BamS GCGGATCCGAAAAAACCATGGAATATAGCATGG 
H325RIAS GCGAATTCCCTCTTTTCAACCACCTCACG 
HHybS GATCTGGTTCCGCGTGGATCCGAAAAAACCATGGAATATAGC 
AatIIS GGACGTCGACGGCGGGGAGCTCGCTG 
AatIIAS GGACGTCGGTACCCGCTTCAAATACGCC 
 
S: Sense primer; AS: Antisense primer 
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Table 2-3: Antibodies used in this study 
 
Antigen Host Reference 
RSP1 Rabbit Yang et al., 2008 
RSP2 Rabbit Yang et al., 2001 
RSP3 Rabbit Yang et al., 2001 
RSP6 Rabbit Yang et al., 2008 
RSP7 Rabbit Yang et al., 2006 
RSP8 Rabbit Yang et al., 2006 
RSP11 Rabbit Yang et al., 2006 
RSP16 Rabbit Yang et al., 2005 
RSP23 Rabbit Yang et al., 2008 
IC140 Rabbit Yang and Sale, 1998 
HA Rabbit Covance Inc., 
GST Mouse Genscript 
Radial spoke Chicken Yang et al., 2005 
Secondary Antibodies   
Anti-chicken IgY-peroxidase Rabbit Sigma 
Anti-rabbit IgG-peroxidase Goat Sigma 
Anti-mouse Ig –peroxidase Goat Sigma 
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2.2 Cell Strains and Culture Conditions 
  
The Chlamydomonas reinhardtii strains used in this study were wild-type strain cc124(-), 
and paralyzed RSP3 mutant strain, pf14. They were obtained from the Chlamydomonas 
Resource Center (Duke University, Durham, NC).  
The cells were grown on Tris-Acetate-Phosphate (TAP) plates for 6-7 days. 
Subsequently a loop of cells were inoculated into ~350 ml TAP liquid medium and 
cultured under aeration in a 14/10 light/dark cycle (Harris, 2009). 
 
2.3 Molecular Biology 
2.3.1 Polymerase Chain Reaction-based DNA Fusion 
To generate small (< 100 bp) truncation constructs a mixed PCR strategy was adopted. 
For instance, to create a vector that expresses GST-RSP3280-308, GST and RSP3280-308 
were amplified. The PCR fragments, 5 ng each, were used as the templates for the fusion 
PCR reaction. They were amplified using three primers: GST forward primer; RSP3308 
reverse primer and a hybrid forward primer that contains the 3’end sequence of GST and 
5’end sequence of RSP3280-308. The resulting PCR product with both coding sequences 
could be cloned into an expression vector using conventional cloning techniques. The 
conditions used for the mixed PCR took into the consideration the annealing temperature 
of all the three primers and DMSO was omitted from the PCR reaction. Other parameters 
were not varied. 
 
2.3.2 Engineering Genomic DNA Constructs  
A NcoI fragment containing the RSP3 genomic DNA was released from a BAC clone  
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Figure 2-1. The PCR strategy for fusing the sequences encoding a large tag and 
a small amphipathic helix. 
 
This method is developed to overcome the difficulty in cloning a small DNA 
fragment for protein expression. The templates for PCR amplification include the 
PCR fragments for GST and for RSP3’s AH. Three primers for PCR amplification: 
the NcoS primer, the RSP3AS primer and the hybrid primer (HybS) which contain 
the 3’ end sequence of GST DNA and the 5’ end sequence of RSP3’s AH. The PCR 
product generated from this reaction is purified and inserted into pET-Duet vector 
digested between the NcoI site and EcoRI site. 
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and inserted into NcoI site in pGEM-T Easy vector (Promega). The SacI site and its 
downstream sequence in the 3’ flanking region were eliminated by limited restriction 
digest followed by treatment with T4 DNA polymerase. PCR with modified primers was 
performed to add the sequence for 6 His codons flanked by XhoI site at one end and stop 
codon followed by Xba site at the other end. Subsequently, a PCR product containing 
3HA-6His coding sequence flanked by XhoI sites was ligated into the XhoI site. This 
fragment was amplified using p3HA plasmid (Silflow et al., 2001) as a template. The 
final RSP3 genomic construct, pRSP3-HAHis expressed a polypeptide with a 3HA and 
12His tag. This construct was used to create all the mutant constructs. All the strains were 
generated using a PCR based approach. 
∆1 
The nucleotide sequences flanking Coil1 (171-244 a.a.) were amplified from pRSP3-
HAHis vector using the following primer pairs: XbaS, XhoAS and XhoS, AS. The PCR 
fragments were digested with XbaI and XhoI; and with XhoI and NotI. The two digested 
fragments, i.e. Xba-Xho and Xho-Not, were ligated into pRSP3-HAHis vector digested 
with SpeI and NotI. XbaI and SpeI generate complementary free ends that allow ligation 
and distinction between the parental DNA and the ligated DNA. For single plasmid 
transformation in Chlamydomonas, this construct was further modified by adding the 
paromomycin (PMM) resistance cassette from pSI 103 plasmid (Yang et al., 2008) into 
the AatII site. This vector is designated as p∆Coil1PMM. 
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Figure 2-2. Cloning Strategy for the generation of pRSP3-3HA-12His. 
 
The pGEM T- Easy vector that contained the sequence encoding the RSP3 genomic 
DNA (bold line) was amplified using primers with 6 His codons flanked by XhoI 
site at one end and a stop codon followed by a Xba site at the other end. This PCR 
fragment along with the Xba-SacI piece was ligated into the SacI site in the pGEM 
T-Easy vector. The sequence encoding the 3 HA tag was amplified from p3HA 
plasmid with primers that contained built in XhoI sites at both ends and also the 
sequence for 6 His codons. The resulting fragment which contained the sequence for 
3HA tag and 6 His codons flanked on either side by Xho I site was cloned into the 
XhoI site thus generating pRSP3-3HA-12His. 
pRSP3-3HA-12His 
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Figure 2-3. Strategy for the generation of RSP3 truncation constructs. 
 
Schematic representing the cloning strategy that was applied to generate the 
various RSP3 truncation constructs. The grey boxes represent the 5’ and 3’ UTR; 
the black boxes depict the exons and the black lines depict the introns. The three 
coils in RSP3 are shown as the colored boxes. The primer pairs utilized to 
generate each construct are also depicted. 
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∆2 
The nucleotide sequences flanking coil2 were amplified from the pRSP3-HAHis vector 
using SpeS and NotAS primers. The amplified fragment was ligated into p∆Coil1PMM 
vector digested with Spe and Not.  
The PMM cassette was also cloned into the AatII site in pGEM-T Easy, and this 
vector (pGEM-T Easy + PMM) was used to generate the remaining RSP3 constructs. 
1-178 
To create the RSP31-178 construct, two fragments were amplified from the pRSP3-HAHis 
vector. The first fragment which extended from the 5’UTR to 178 aa was generated using 
a EcoRIS primer with a built in EcoRI site and an antisense primer (XbaAS3) with a built 
in Xba site. The second fragment which extended from the 3HAHis tag to the 3’UTR was 
generated using a sense primer with a built in Xba site (XbaStag) and an antisense primer 
with a built in EcoRI site (RIAS). The two fragments (RI-Xba and Xba-RI) generated by 
PCR were ligated into the pGEM-T Easy + PMM template digested with RI. 
1-244 
To create the RSP31-244 construct, flanking sequences were amplified using the same set 
of primers that were used to make RSP31-178, except XbaAS3 primer was replaced with 
the XbaAS2 primer, which resulted in a fragment extending from the 5’UTR to 244 aa. 
The second fragment which extended from the 3HAHis tag to the 3’UTR was generated 
using a sense primer with a built in Xba site (XbaStag) and an antisense primer with a 
built in EcoRI site (RIAS). The two fragments (RI-Xba and Xba-RI) generated by PCR, 
were ligated into the pGEM-T Easy + PMM template digested with RI. 
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1-316 
To create the RSP31-316 construct, flanking sequences were amplified using the same set 
of primers that were used to make RSP31-178, except XbaAS3 primer was replaced with 
the XbaAS1 primer which resulted in a fragment extending from the 5’UTR to 316 a.a. 
The second fragment which extended from the 3HAHis tag to the 3’UTR was generated 
using a sense primer with a built in Xba site (XbaStag) and an antisense primer with a 
built in EcoRI site (RIAS). The two fragments (RI-Xba and Xba-RI) generated by PCR, 
were ligated into the pGEM-T Easy + PMM template digested with RI. 
1-269 
To create the RSP31-269 construct, two fragments were amplified from the pRSP3-HAHis 
vector. The first fragment which extended from the 5’UTR to 269 a.a. was generated 
using the EcoRIS primer and ICAS primer with a built in Xho site. The second fragment 
which extended from the 3HAHis tag to the 3’UTR was generated using a sense primer 
with a built in Xho site and RIAS primer. The two fragments (RI-Xho and Xho-RI) 
generated by PCR, were ligated into the pGEM-T Easy + PMM template cut with RI. 
 
2.3.3 Engineering cDNA Constructs 
  i)  GST-tagged RSP396-180; RSP3245-316 and RSP3269-316 
The constructs expressing GST tagged RSP396-180, RSP3245-316 and RSP3269-316 were made 
by first amplifying the corresponding sequences from GST-RSP3 cDNA as a template 
(Diener et al.,1993) using a sense primer with a built in Bam site and an antisense primer 
with a built in RI site. The PCR products were then inserted into pGEX-2T vector 
digested with Bam and RI.  
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ii) GST-tagged RSP3269-298 
RSP3269-316 in pGEX-2T was used as the template. The sequence corresponding to 
RSP3269-298 inclusive of the GST tag was amplified. The NcoS primer with a built in Nco 
site annealed to the GST tag and the 298RIAS primer was used to amplify the RSP3 
sequence. The resulting fragment which consisted of GST-RSP3269-298 was inserted into 
pET-Duet vector (Novagen) digested with Nco and RI.  
iii) GST- tagged RSP3280-316; RSP3280-306 and RSP3280-308 
The constructs for expressing these short fragments were modified from the pGEX-
RSP3245-316. The PCR fusion strategy was employed to fuse the coding sequences for 
GST and a RSP3 fragment. The fused PCR fragment was inserted into pET-Duet vector 
digested with Nco and RI. 
iv) RSP3280-316V300P 
The pRSP3280-316 was used as the template to replace V300 into P using QuikChange 
Site-Directed mutagenesis strategy (Stratagene). The resulting plasmid is named 
pRSP3V300P. 
v) His-tagged full length Dpy-30 (FL) 
To create the His –tagged Human Dpy-30 full-length construct the sequence was 
amplified from a commercially available cDNA clone using a sense primer with a built-in 
NdeI site and an antisense primer with a built-in XhoI site. The fragment was inserted 
into pET-28a vector digested with NdeI and XhoI.  The resulting construct expressed N- 
terminally- tagged Dpy-30.  
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vi) His- tagged Dpy-3045-99 
The Dpy-3045-99 construct expresses the Dpy-30 domain in the Dpy-30 protein. The 
sequence was amplified using a sense primer with a built-in PstI site and an antisense 
primer with a built-in NheI site. The PCR fragment is inserted into a modified pET-28a 
vector that has a coding sequence for TEV protease cleavage site inserted downstream to 
8 His codons, pET28a-H8-TEV (kindly provided by Dr. St.Maurice). 
vii) GFP- tagged Ash2 
The coding sequence for Ash2’s AH was PCR-amplified from a human cDNA clone 
obtained from Open Biosystems. GFP sequence was amplified from a plasmid obtained 
from Lechtreck and Witman (2009). The PCR products were fused together using the 
PCR fusion strategy and cloned into the PstI site in the pET28a-H8-TEV vector. 
 
2.3.4 Transformation of Chlamydomonas 
All genomic constructs were transformed into the RSP3 mutant strain, pf14 using the 
glass beads method (Kindle, 1990). Cells were grown in ~350 ml TAP media under light 
and dark cycle to a mid-log phase and for an additional 24 hours under constant light. 
The cells were spun down at 1,500 rpm for 5 minutes and treated with autolysin at a 
concentration of 1x107 cells/ml until > 50% of the cells were lysed by 0.5% Nonidet-P40. 
The autolysin-treated cells were washed with TAP medium and resuspended in the same 
solution to a final concentration of 1 × 108 cells/ml. Aliquots of 300 µl cells were added 
into each tube. Glass beads, 1-3 µg plasmids and 100 µl freshly prepared 20% PEG 8000 
were then added to the tubes, followed by vortexing for 45 sec at speed 8 (Mini Vortexer, 
VWR). Afterwards, 10 ml TAP media was added into the tube immediately. The cells 
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were spun down gently in IEC clinical centrifuge at #3 setting for 5 min and resuspended 
in fresh TAP media (5 ml) and recovered under light overnight. The next day the cells 
were spun down again and the pellet was resuspended in 500 µl TAP and plated on TAP 
agar plates with 10 µg/ml PMM. Individual colonies became visible in 5 days. The 
colonies were re-streaked onto a fresh TAP plate. 
 
2.4 Cell Biology 
2.4.1 Microscopic Screening of Transformants 
A small fraction of the growth from single colonies was resuspended in TAP medium or 
water (200 µl) in 96-well plates for motility analysis using the inverted compound 
microscopes (Olympus IX51).   
 
2.4.2 Electron Microscopy 
Purified axonemes were spun down at 15,000 rpm for 20 minutes in a microfuge. The 
supernatant was discarded and the pellet was fixed with the primary fixative (25% 
glutaraldehyde and 10% tannic acid/0.2 M cacodylate buffer, pH 7.4) for 1 hour on ice. 
The primary fixative was discarded and the pellet was washed twice for 5 minutes each 
with 0.1 M cacodylate buffer. After washing, the pellet was fixed with the secondary 
fixative (4% osmium tetroxide/0.2 M cacodylate buffer, pH 7.4,) for 1 hour at room 
temperature. After two washes, 5 minutes each, with 0.1 M cacodylate buffer, the pellet 
was dehydrated sequentially with 50, 70, 80, 95 and 100% ethanol. The pellet was then 
transferred to a glass vial containing 10:1 ratio of epoxy resin mixture (EMBed 812, 20 
ml; DDSA, 9 ml; NMA, 12 ml; and DMP30, 0.62-0.82 ml) and propylene oxide. The 
resin was allowed to infiltrate the pellet for 24 hours at room temperature. The pellet was 
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transferred to a glass vial containing fresh epoxy resin and incubated at 60°C under 
vacuum for 48 hours. The blocks were sectioned, stained and the images were taken as 
described (Yang et al., 2008). The blocks were prepared by us while the sectioning and 
images were taken by our collaborators at Oklahoma State University. 
 
2.5 Biochemistry  
2.5.1 Screening of Transformants: Flagella Miniprep 
The growth from one re-streaked single colony was resuspended in 1 ml TAP media and 
plated on a TAP plate. After 5-6 days of growth, the cells were recovered and 
resuspended in 1 ml water containing 5.44 mM CaCl2. The resuspended cells were placed 
under light for about 1-2 hours to allow hatching and flagella generation. The cells were 
spun down at 1,500 g for 10 minutes (Sorvall RC6+, Thermo Scientific). The pellet was 
resuspended in 5 ml HMDS (10 mM Hepes, 5 mM MgSO4, 1 mM dithiothreitol and 4% 
sucrose) solution and 0.013 mM dibucaine was used to deflagellate the cells. The cells 
were spun down at 1,500 g for 10 minutes and the flagella-containing supernatant was 
collected. A 25% sucrose cushion in HMDS was added to the supernatant and centrifuged 
at 1,500 g for 7 minutes (Clinical centrifuge, IEC, Swinging bucket rotor). The 
supernatant was centrifuged at 13,000 g for 5 minutes. The pellet which contains the 
flagella was resuspended in Buffer A (10 mM Hepes, 5 mM MgSO4, 1 mM 
dithiothreitol, 0.5 mM EDTA, 30 mM NaCl, 0.1 mM PMSF, 0.5 TIU/ml Aprotinin, pH 
7.4). The samples were fixed with 5X sample buffer for SDS-PAGE and were analyzed 
by western blot. 
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2.5.2 Extraction of Axonemal Proteins 
Chlamydomonas cells were grown in ~ 350 ml TAP liquid medium for about three days 
in 14/10 hour light and dark cycle. The cells were harvested by centrifugation at 1500 g 
for 5 minutes (TA-10 rotor; Allegra 25R centrifuge; Beckman Coulter). The pellet was 
resuspended in 20 ml HMDS solution (10 mM Hepes, 5 mM MgSO4, 1 mM 
dithiothreitol and 4% sucrose). The cells were deflagellated using 50 mM dibucaine (1 
ml/ L cell culture) followed by the addition of protease inhibitors, including 0.1 mM 
PMSF, 0.5 TIU/ml aprotinin and 0.5 mM EGTA. The cell bodies were separated from the 
flagella by centrifugation in a clinical centrifuge at speed #4 for 7 minutes. The 
supernatant was underlayed with 5 ml 20% sucrose and centrifuged at 1500 g for 7 
minutes (Clinical Centrifuge, IEC). The upper layer was centrifuged at 12,000 g for 10 
minutes using TA-14 rotor; Allegra 25R centrifuge. The pellet containing flagella was 
resuspended in Buffer A (10 mM Hepes, 5 mM MgSO4, 1 mM dithiothreitol, 0.5 mM 
EDTA, 30 mM NaCl, 0.1 mM PMSF, 0.5 TIU/ml Aprotinin, pH 7.4) and demembranated 
with 0.5% Nonidet-P40 for 20 minutes. The axonemes were recovered by centrifugation 
at 12000g for 10 minutes. The pellet was resuspended in ~300µl Buffer A. The protein 
concentration was determined using the Bradford assay. The axoneme samples were 
resuspended in Buffer A and fixed in sample buffer for SDS-PAGE at a concentration of 
2 mg/ml. 
 
2.5.3 Fractionation of Axonemal Proteins 
To extract radial spoke complex, the isolated axonemes were resuspended in 0.6 M 
potassium iodide (KI) / buffer A at 5 mg/ml for 30 minutes on ice. The mixture was 
47 
 
 
centrifuged at 12,000 g for 10 minutes. The supernatant was dialyzed in Buffer A for 30 
minutes on ice. The dialyzed liquid was centrifuged at 12,000 g for 10 minutes. The 
supernatant was overlaid on an 11 ml 5-20% sucrose gradient. The gradient was 
subjected to velocity sedimentation at 36,000 rpm (SW41 rotor, Beckman Coulter) for 
10-16 hours at 4°C. 500 µl fractions were collected using the Econo peristaltic pump 
(Bio-Rad). The fractions were fixed with 5X sample buffer for SDS-PAGE. 
 
2.5.4 SDS-PAGE 
Protein samples fixed with 5X sample buffer (10% SDS, 50% glycerol, 0.3 M Tris pH 
6.8, 5% β-mercaptoethanol, 0.05% bromophenol blue) were boiled for 5 minutes at 
100°C. The samples were loaded onto different percentage 8cm X 7cm minigels. The 
electrophoresis was performed using 1X running buffer (27 mM Tris Base, 0.1% SDS 
and 170 mM Glycine) as described by Laemmli (1970, 1973). A 5µl aliquot of molecular 
weight marker (Fermentas) was used. Electrophoresis was carried out with Protean III 
mini-gel apparatus (Bio-Rad) at 190 V for 0.5- 1 hour. 
 
2.5.5 Native-PAGE 
Protein samples were fixed with 5X sample buffer (50% glycerol, 0.3 M Tris pH 6.8, 5% 
β-mercaptoethanol, 0.05% bromophenol blue). The samples were loaded onto different 
percentage 8cm X 7cm native gels. Electrophoresis was performed using 1X running 
buffer (27 mM Tris Base and 170 mM Glycine) (Ornstein, 1964; Davis, 1964). 1 mg/ml 
BSA was fixed with 5X sample buffer for Native-PAGE and used as the marker. 
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Electrophoresis was carried out with Protean III mini-gel apparatus (Bio-Rad) at 190 V 
for 0.5- 1 hour. 
 
2.5.6 Western Blot 
After gel electrophoresis, the proteins fractionated in the gel were transferred onto a 
nitrocellulose membrane. Depending on the size of the protein being transferred a 0.45 
µm pore size membrane (> 40 KDa) or a 0.2 µm pore size membrane (< 40 KDa) (Pall 
Corporation) was used. The transfer cassette which consisted of sponge, filter paper, gel 
and membrane was placed into the gel box. The transfer was carried out using either Big 
protein transfer buffer (> 40 KDa) (0.38 M glycine, 50 mM Tris base, 10% SDS, 20% 
methanol) or small protein transfer buffer (< 40 KDa) (0.19 M glycine, 25 mM Tris base, 
20% methanol). The transfer was carried out at 100 V for 50-60 minutes in a mini-gel 
transfer apparatus (Bio-Rad). Following transfer, the membrane was stained with 
Ponceau S (0.2% Ponceau S, 3% trichloroacetic acid, 3% sulfosalicylic acid) for about 2 
minutes. The membrane was destained with deionized water. Subsequently the membrane 
was blocked with 5% non-fat milk in 1X TBS, pH 7.4 (0.14 M NaCl, 2.6 mM KCl, 25 
mM Trizma base) for 1 hour at room temperature. The blocked membrane was incubated 
with primary antibody for 2 hours at room temperature. The blot was washed thrice, 5 
minutes each, with 1 X TBS, followed by incubation with secondary antibody for 2 hours 
at room temperature. The blot was washed again thrice with 1 X TBS. The protein bands 
were then revealed by enhanced chemiluminescence (ECL) using a mixture of two 
solutions: solution 1 (0.5 ml 1 M Trizma base pH 8.8, 50 µl 44 mg/ml luminol, 22 µl 15 
mg/ml p-coumaric acid and 4.4 ml H2O) and solution 2 (0.5 ml 1 M Trizma base, pH 8.8, 
49 
 
 
3 µl 30% H2O2 and 4.5 ml H2O). The blot was incubated with this mixture for 1 minute. 
The blot was then exposed to autoradiography film (Denville Scientific) for different 
periods of time and developed with an automatic film processor CP1000 (AGFA 
healthcare). 
 
2.5.7 Ni-NTA Affinity Purification 
The vectors encoding GST-tagged RSP3 constructs and the His-tagged Dpy-30 constructs 
were co-transformed into BL21 (DE3) cells. The transformants were inoculated into 5 ml 
LB liquid medium supplemented with appropriate antibiotics. The liquid cultures were 
incubated at 37°C in a shaker for ~2-3 hours (OD ~0.4-0.6). Following this the culture 
was induced using 1mM IPTG, overnight at 16°C. Following induction, the cells were 
spun down at 10,000 g for 1 minute. The cell pellet was resuspended in 750 µl Lysis 
Buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) and sonicated using 
a Branson digital sonifier. The sonicated cells were spun down at 12,000 g for 25 min at 
4°C. 50 µl of the supernatant was saved as ‘pre’. The rest of the supernatant was applied 
to Ni-NTA matric (100 µl) and incubated at room temperature for 1 hour. Following 
incubation the mixture was spun down and 50 µl of the supernatant was saved as flow 
through or ‘post’. The rest of the supernatant was discarded. The beads were washed 
thrice using the wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 
8.0). Following the washes the bound protein was eluted using the elution buffer (50 mM 
NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0). The samples were fixed in 5X 
sample buffer and fractionated on SDS PAGE gels. The gels were blotted onto 
nitrocellulose membranes and probed using the monoclonal GST antibody (Genscript). 
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2.5.8 Overlay 
Axonemal samples or bacterial samples were fractionated on SDS-PAGE gels. The gels 
were transferred to nitrocellulose membrane (Ponceau staining is omitted). The blot was 
blocked with 5% non-fat milk pH 7.4 in 1X TBS (0.14 M NaCl, 2.6 mM KCl, 25 mM 
Tris base) for 30 minutes at room temperature. The blot was probed with 2 µg/ml purified 
Dpy-30 protein for 2.5 hours at room temperature. The blot was washed once with 1 X 
TBS. Subsequently the blot was probed with anti-Dpy30 antibody. The blot was washed 
once with 1 X TBS and then incubated with horse radish peroxidase-conjugated anti-
rabbit secondary antibody. The blot was washed once with 1 X TBS and developed using 
enhanced chemiluminescence. The No ligand control was processed identically except 
that the blot was not probed with Dpy-30 protein. 
 
2.5.9 Chemical Blocker Screening with Native Gel Electrophoresis 
The mixture of 2 µg of each protein in PBS was incubated at room temperature for 1.5 
hours. Subsequently the reaction mixture was fixed with 5X native gel sample buffer. 
The samples were fractionated on a native gel and visualized by Coomassie staining.  
To identify compounds that inhibit the RSP3-Dpy-30 interaction, 2 µg purified 
Dpy-30 was incubated with different compounds, at 25 µM, for 1 hour at room 
temperature. Subsequently, purified GST-tagged RSP3 peptides were added to the 
mixture to a final concentration of 1 µg/µl. After 1-hour incubation at room temperature, 
the samples were fixed with sample buffer for Native PAGE and fractionated on a native 
gel. The proteins were visualized by Coomassie stain. 
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2.5.10 Chemical Blocker Screening with Ni-NTA Pull-Down 
Aliquots of purified Dpy-30 protein were incubated with 50 µM compound  for 1 hour at 
room temperature. Following the incubation, the mixture was incubated with purified 
GST-tagged RSP3 peptides at room temperature for 1 hour. A fraction of the mixture is 
saved as ‘pre’ sample. To the remaining mixture, 20 µl Ni-NTA matrix were added and 
the sample was incubated at room temperature for 1 hour. Following the incubation, the 
reaction mixture was spun down and a fraction of the supernatant was saved as ‘post’ 
sample. 5X sample buffer for SDS-PAGE was added to the rest of the beads and spun 
down. The supernatant along with the pre and post samples were fractionated on a SDS-
PAGE gel and visualized by Coomassie stain. 
 
2.6 Sequence Analysis 
Sequence alignments were generated using ClustalW2 program (http://www.ebi.ac.uk/ 
Tools/msa/clustalw2/). Coils program was used to define regions with high propensity to 
form coiled coils (http://www.ch.embnet.org/software/COILS_form.html). PyMOL 
(DeLano, 2002) was used to visualize the crystal structures of RIIa clan domains and also 
align the structures. Secondary structure predictions were made using HNN (http://npsa-
pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_nn.html). Pfam database (http://pfam. 
sanger.ac.uk/) was used to define proteins that contain RIIa clan domains. 
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Chapter 3: RSP3 Forms the RS Scaffold with Two Distinct    
Sites that Anchor RIIa Clan Domains 
 
 
3.1 Introduction 
Anchoring proteins are used by eukaryotic cells to localize molecules involved in signal 
transduction, such as kinases, phosphatses, GTPases and phosphodiesterases (Scott and 
Pawson, 2009; Klauck et al., 1996). This concept was founded on the discoveries of 
anchoring proteins for cAMP-dependent protein kinase (PKA), the key effector 
mechanism for cAMP (Theurkauf and Vallee, 1982). The PKA holoenzyme contains two 
catalytic subunits and two regulatory subunits, RI or RII. Although PKA plays a central 
role in the regulation of many cellular reactions, it has broad substrate specificity. It was 
discovered that cells contain various A-Kinase Anchoring Proteins (AKAPs) to target this 
promiscuous enzyme to specific sub-cellular locations (Welch et al., 2010).   
Anchoring of PKA is mediated by a 14-18 a.a. amphipathic helix in AKAPs and 
the RIIa domain in the regulatory subunit, RI or RII, in PKA (Carr et al., 1991). Many 
AKAPs were identified solely based on the presence of an AH and the binding of RII in 
vitro. However, the RIIa domain is not restricted to PKA alone. It has been found in 
numerous proteins associated with various flanking sequences. Another RIIa like domain 
known as the Dpy-30 domain is also found in equally numerous molecules with diverged 
architectures. Together, all these proteins are classified into two subfamilies under the 
RIIa clan in the Pfam database. 
Interestingly, two proteins from each subfamily are subunits of the radial spoke 
complex, a key regulatory element within the 9+2 axonemal machinery. RSP7 and 
RSP11 contain a RIIa domains while RSP2 and RSP23 contain Dpy-30 domains (Yang et 
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al., 2006). These four proteins may contribute partly to the mechanism of this molecular 
complex. 
During flagellar beating, the RS couples the mobile CP with the dynein motors 
that are attached to the outer doublets (Warner and Satir, 1974; Smith and Yang, 2004). 
Precise coupling of these elements is critical for flagella to bend and to propagate the 
bend. Consistently, RS appears rather rigid with slight elasticity under electron 
microscopy. We reason that the rigidity for effective coupling of RS and the mobile CP 
must be based on a single molecule extending throughout the spoke stalk as a core to 
associate with other RS constituents that confer the effector mechanisms of the RS. The 
first generation models in which the stalk is comprised of a string of RSPs (Yang et al., 
2006) are not likely to provide the necessary rigidity. Among the 23 RSPs, the best 
candidate for this scaffold protein is RSP3.   
First of all¸ a 300-a.a. region near the N-terminus is evolutionarily conserved, in 
sequence as well as in length. The homology in length is consistent with the 
extraordinarily conserved dimension of the RS and 9+2 axonemes from diverse 
organisms (Mastronarde et al., 1992; Nicastro et al., 2006). Secondly, it was 
demonstrated that RSP3 is essential for the assembly of the radial spoke (Huang et al., 
1981; Williams et al., 1989). Its N-terminus directly binds to the axonemes (Diener et al., 
1993). In addition, a downstream AH interacts with the RIIa domain (Gaillard et al., 
2001), presumably for binding the two RIIa RSPs. If RSP3 is the scaffold, sequence 
toward the C-terminus will bind the Dpy-30 domain in RSP2 and RSP23. Thus we 
hypothesize that the dimeric spoke AKAP, RSP3, forms the radial spoke scaffold and 
contains two distinct sites that anchor the RIIa clan RSPs.  
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This chapter describes in two sections the two main strategies that were taken to 
test this hypothesis. The results from independent approaches consistently support the 
hypothesis and demonstrate that RSP3 contains two distinct sites that associate with the 
RIIa domain and the Dpy-30 domain respectively. Anchoring through these sites and the 
RIIa clan domains localizes the rest of the molecular modules in these four RSPs to 
precise locations for the assembly and modulation of the RS. The in vitro investigation 
further defined the amphipathic binding site for the Dpy-30 domain.  
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Section 1: In vivo approach 
Sequence analyses were performed to identify the regions that may bind the Dpy-30 
domain. Based on the prediction, truncation constructs of RSP3 genomic DNA were 
engineered and Chlamydomonas mutants were generated. The mutant strains were 
subjected to motility, biochemical and morphological analyses. 
 
3.2 Results 
3.2.1 Sequence Analysis of RSP3 
We reason that the organization of the four RIIa clan members in the RS stalk must be 
conducive to the predicted key property of the stalk-- rigidity—in order for the RS to 
mechanically couple the mobile CP and outer doublets at a high frequency (Warner and 
Satir, 1974). Higher rigidity may come from a RS with all four RIIa clan members 
docking to a single or dimeric fibrous molecule extending throughout the complex than a 
RS made from a continuous chain of individual RIIa clan members. The core molecule 
that anchors the RIIa clan members should be long enough to span the distance from the 
outer doublets to the CP. Furthermore, it should be conserved, as the dimension of 
various axonemes is similar (Mastronarde et al., 1992; Nicastro et al., 2006). Sequence 
analyses showed that among the 19 spoke components, the best candidate is RSP3, the 
dimeric spoke AKAP which has the dimensions necessary to span the distance of the 
spoke stalk (Discussed in Chapter 5) (Wirschell et al., 2008; Gaillard et al., 2001).   
 The AHR (a.a.# 161-178) (Gaillard et al., 2001) separates RSP3 into two 
segments (Figure 3-1A): the N-terminal disordered region that binds axonemes (Diener et  
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Figure 3-1. Sequence analyses and the model of RS. 
 
(A) The secondary structure of RSP3 appears to be divided into two distinct areas by 
the RIIa-binding site (red underline). The N-terminal 160 a.a. contains random coils 
(purple) interspersed with short α-helices (blue) and β-strands (red), while the C-
terminus is primarily composed of α-helices. Black bar, the RSP3 domain highly 
conserved among RSP3 orthologues; Grey bar, the axoneme-binding region. (B) 
RSP3 contains three areas with propensity to form coiled coils. The prediction was 
made by Coils program using the window size of 28 a.a.. (C) A model depicting 
RSP3 dimer (black and gray lines) as the core in the RS, with two sites for anchoring 
RIIa (R) and Dpy-30 (D), dimerization and docking domains in two pairs of RSPs.  
Each domain tethers distinct molecular moieties as effector mechanisms, like an 
armadillo repeat protein (ARM), the calcium- binding EF-hands (Ca), coiled coils 
(blue bars), nucleoside diphosphate kinase (NDK), RIIa binding amphipathic helix 
(AHR). 
A 
B 
C 
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al., 1993; the grey bar) and a stack of LC8 dimers (Gupta et al., unpublished); and the C-
terminus that is largely helical with a propensity to form three coiled coils (Figure 3-1B). 
Coiled coils are known to promote protein-protein interactions. The N-terminal ~320-a.a. 
region, upstream to Coil 2, is highly conserved and is recognized as a RSP3 domain by 
the Pfam database (the black bar). Coil 2 is mildly conserved, whereas the C-terminus 
including Coil 3 is unique to Chlamydomonas and is dispensable (Diener et al., 1993). 
Thus we postulate that the dimer of the conserved region in RSP3 forms the core of the 
RS, with binding sites for the axoneme as well as RIIa domain, Dpy-30 domain and 
possibly the spokehead (Figure 3-1C). 
 
3.2.2 RSP3 Truncation Mutagenesis Clarifies the Binding Region for the RIIa 
Domain and its Tethered Moieties 
 
Although point mutations in RSP3’s AHR abrogates the interaction of RSP3 with RII in 
an overlay assay (Gaillard et al, 2001), the mutant strain expressing the same mutated 
RSP3 polypeptide did not perturb the assembly of the RIIa-domain containing proteins 
RSP7 and RSP11 (Gaillard et al., 2006). We predict that the inconsistency is because 
RSP7 and RSP11 engage in multiple interactions with RSP3 and hence an alteration in 
the AHR-RIIa interaction alone is insufficient to prevent their assembly. Therefore in 
order to test whether the AH anchors the RIIa domain in RSP7 and RSP11, it is also 
necessary to delete the area associated with their effector mechanisms. If the hypothesis 
is correct, deletion of all involved sequences in RSP3 will result in an axoneme devoid of 
these two molecules and possibly their associated molecules, such as RSP8 with ARM 
repeats that are known to promote protein-protein interactions. Alternatively, retention of 
the AHR alone may be sufficient to restore these two molecules. To alleviate folding 
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issues due to inappropriate deletions, the designs of RSP3 deletion constructs were 
guided by the predicted secondary structure.  
Toward this end, we first created two complementary strains: the 1-178 strain that 
terminates at the end of the AHR; and ∆1 strain lacking Coil 1 (a.a.# 171-244) and part of 
the AHR. The third strain, ∆2, that lacks the small Coil 2 (#316-354), served as a control.  
All truncated polypeptides retained the axonemal binding region at the first 80 a.a. and 
thus could be assembled into the axoneme. To protect the truncated ends and to detect the 
truncated polypeptide, the C-terminus of all RSP3 polypeptides was tagged with 3 HA 
epitopes and 12 His residues. The tag also allowed quantitative comparison of the 
truncated RSP3 variants in the axoneme.  
All of the constructs for creating RSP3 mutant strains were modified from a 
plasmid carrying the wild type (WT) RSP3 genomic DNA that was recovered from a 
BAC clone. The truncated constructs were transformed individually into the RSP3 mutant 
pf14 in which a premature stop codon results in diminished expression of the RSP3 
polypeptide missing the axonemal binding site at the N-terminus (Williams, et al., 1989; 
Diener et al., 1993). Since RSP3 mutants defective in the conserved region are paralyzed 
like pf14 (Diener, et al., 1993), some of the truncated strains were expected to be 
paralyzed as well. To aid the differentiation of paralyzed RSP3-positive clones from 
paralyzed parental cells, an antibiotic resistance cassette was inserted into the plasmid for 
single–plasmid transformation. The transformants were first selected for antibiotic 
resistance. More than 100 antibiotic-resistant clones for each construct were screened 
microscopically. All clones in both ∆1 and 1-178 groups were paralyzed. On the other  
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a
  The suspension contains swimmers. 
b
 The quantity from each quick flagellar preparation varied.  The yield of some clones 
was low because of fewer flagellated cells or had difficulties in shedding flagella. 
 
 
 
 
 
 
 
 
 
 
 
 
Construct # observed # Motilea # for flagella prep.b # HA + 
∆1 160 0/160 23 5/23 
∆2 118 50/118 16 7/16 
1-178 40 0/40 10 2/10 
Table 3-1. Screening of RSP3 truncation mutants. 
 
 Single colonies of antibiotic-resistant transformants were randomly picked and re-
streaked on agar plates. A fraction of each colony was resuspended for light 
microscopy. A crude flagella preparation was made from a plate of clones randomly 
selected from the group of ∆1 and 1-178 that were 100% paralyzed; or from the 
clones with swimmers from the group of ∆2. The samples were then assessed by HA 
western blots.  #, colony numbers.  
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hand, among the 118 ∆2 clones screened, 50 clones contained motile cells (Table 3-1), 
indicating substantial amount of ∆2-RSP3 polypeptides were restored to the axoneme of 
40% of the antibiotic-resistant strains. In the case of the paralyzed clones, the plasmid 
may not have inserted into the genome properly to express the truncated RSP3 in 
sufficient quantity. These data suggest that ∆2-RSP3 can restore the motility to pf14 
flagella, whereas ∆1 RSP3 cannot rescue the motility, even if the truncated polypeptides 
are restored to the axonemes.  
A quick preliminary screen was conducted to identify clones with truncated RSP3 
in their flagella. 10 clones were randomly selected from the paralyzed ∆1 and 1-178 
groups; and from the motile clones in the ∆2 group. A small crude flagella preparation 
was made from a plate of each clone for HA western analysis (not shown). The clones 
with HA-positive flagella were cultured in liquid media for axoneme preparations. 
Western blots of near equal loads of axonemes were probed for representative RSPs 
(Figure 3-2). The clone expressing wild type (WT) RSP3-HAHis served as the positive 
control. The negative control was the spoke-less pf14. The representative HA western 
blots showed that in all strains except pf14, the amount of RSP3 variants in axonemes 
were similar. For the ∆1 strain that was missing Coil 1 (a.a.# 171-244) that includes part 
of the AHR (a.a.# 161-178) in RSP3, both the RIIa-containing RSP7 and RSP11, as well 
as RSP8, the ARM repeat protein, were absent (Figure 3-2), while all the proteins in the 
spoke head and neck region were present at normal levels. The assembly of the Dpy-30-
containing RSPs at the neck when the RIIa-containing RSPs located between the neck 
and the base are absent indicates that the RS is not comprised of a string of individual 
RIIa clan RSPs. Conversely the 1-178 axonemes, in which the entire AHR  
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Figure 3-2. Truncation around the Coil 1 region results in deficiencies in RIIa-
domain-dependent assembly.  
 
Western blots of axonemes (left panel) from WT and the RSP3 strains defective in 
the region around coiled coils (right panel) were probed for relevant RSPs as 
indicated. The RIIa proteins (RSP7 and 11) and the ARM (RSP8) were missing in 
the ∆1 strain in which half of the RIIa-binding AH is truncated. These proteins 
appeared normal in ∆2 axoneme. The 1-178 axonemes that contains RSP3 sequence 
up to the AH lacked all the proteins in the spokehead and spokeneck but contained 
the RIIa proteins (RSP7 and RSP11). Note RSP8 was less abundant. The spoke-less 
pf14 was the negative control. IC140, an inner dynein arm subunit, indicated the 
protein loading.  
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(a.a.# 161-178) was retained, both RSP7 and RSP11 were present, but the spoke  head 
proteins (RSP1, RSP4, RSP6) and neck proteins (RSP2, RSP23 and RSP16) were absent 
(Figure 3-2). Therefore, AHR is sufficient to anchor the two non-PKA RIIa proteins. Note 
RSP8 was less abundant in 1-178 axonemes than in the WT, like the axoneme of the 
RSP11 mutant pf25 that lack RSP11 (Yang et al., 2006). The RSP8 deficiency in the 
axoneme defective in Coil 1 (1-178 or ∆1) or lacking RSP11 supports the prediction that 
RSP11 and RSP8 form a tri-molecular sub-complex with RSP3 Coil 1 region (Figure 3-
1C). Furthermore, the fact that the C-terminus up to Coil 3 is dispensable (Diener et al., 
1993); and Dpy-30-domain-containing RSP2 and RSP23 are absent in 1-178 strain but 
normal in ∆1 and ∆2 strains suggest that the Dpy-30-domain-binding site is located 
between Coil 1 and Coil 2. 
 
3.2.3 A Downstream Helical Region Associates with Dpy-30 Domain Containing 
Proteins  
 
To define the Dpy-30-domain-binding region in RSP3, we took the same strategy to 
generate three more strains in which RSP3 terminated at different residues between Coil 
1 and Coil 2, i.e. a.a.# 244, 269, 316 respectively. As expected, all clones in the 1-244 
and 1-269 groups were paralyzed (Table 3-2). As the ∆2 group, approximately 40% of 
the clones in the 1-316 group contained swimmers. This further confirms that the less 
conserved Coil 2 region is dispensable. Preliminary western blots of flagella from 
selected clones identified the RSP3 (HA)-positive clones. The axonemes from these 
clones were subjected to detailed analyses. 
Western blots showed that the axonemes from the paralyzed 1-244 and 1-269 
strains, like the 1-178 strain, were deficient in the neck proteins (RSP2, RSP23 and  
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Construct # observed # Motilea # for flagella prep.b # HA + 
1-244 50 0/50 10 3/10 
1-269 92 0/92 10 2/10 
1-316 114 47/114 10 7/10 
            
a
  The suspension contains swimmers. 
b
 The quantity from each quick flagellar preparation varied.  The yield of some 
clones was low because of fewer flagellated cells or had difficulties in shedding 
flagella. 
 
Table 3-2. Screening of RSP3 truncation mutants.  
 
Single colonies of antibiotic-resistant transformants were randomly picked 
and re-streaked on agar plates. A fraction of each colony was resuspended for 
light microscopy. A crude flagella preparation was made from a plate of 
clones randomly selected from the group of 1-244 and 1-269 that were 100% 
paralyzed; or from the clones with swimmers from 1-316 group. The samples 
were then assessed by HA western blots.  #, colony numbers.  
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Figure 3-3. Truncation between the first two coils results in deficiencies in Dpy-30-
domain-dependent assembly.  
 
Western blots of axonemes (left panel) extracted from WT and three mutants with 
different truncations distal to Coil 1 (right panel) were probed for relevant RSPs as 
indicated. 1-244 strain and 1-269 strain were deficient in the spokehead proteins and the 
spokeneck proteins including RSP16 and the two Dpy-30-domain- containing RSP2 and 
RSP23. These proteins were present in 1-316 strain but the spokehead proteins were less 
abundant than that in the WT control. The spoke-less pf14 was the negative control. 
IC140, an inner dynein arm subunit, indicated the protein loading. 
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RSP16) and the head proteins (RSP1, RSP4 and RSP6) (Figure 3-3). This suggests that  
the region involved in the head-neck assembly and anchoring the Dpy-30 domain is 
within a.a.# 269-316 in RSP3. For the 1-244 and 1-269 strains that retain both AHR and 
Coil 1, the axoneme had normal amounts of RIIa-domain-containing RSP7 and RSP11 as 
well as the ARM repeat protein RSP8. This result further supports the prediction that the 
mutually interacting RSP11 and RSP8 bind to AHR and Coil 1. 
In 1-316 axonemes in which RSP3 lacks both Coil 2 and Coil 3, the Dpy-30-
domain- containing RSP2 and RSP23, and RSP16 were present in normal levels as 
expected (Figure 3-3). The head proteins (RSP1, RSP4 and RSP6) were also present, yet 
their amounts were drastically reduced compared to WT axonemes. These head proteins 
were also less abundant in the RSP2 mutant pf24 (Huang et al., 1981; Patel-King et al., 
2004; Yang et al., 2006). The same spokehead deficiencies due to the defect either in 
RSP2 or in the C-terminus of RSP3 suggests that RSP2 and RSP3 Coil 2 region are both 
involved in the assembly of the spokehead. Furthermore, the 47-a.a. RSP3269-316 may 
anchor the Dpy-30 domain directly. The precise binding site was determined by in vitro 
experiments described later. 
 
3.2.4 Truncations in RSP3 Lead to Smaller Spoke Particles 
To assess the RSs with truncated RSP3 independently, we took two more approaches. 
Firstly, RSs were extracted from axonemes with KI buffer and the dialyzed extract was 
fractionated by sucrose gradient velocity sedimentation. The fractions of the gradient 
were then assessed by western blots (Figure 3-4). The RS complex from the WT control 
sample sedimented as an intact particle with a single 20S peak (Yang et al., 2001). For all   
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Figure 3-4. Radial spokes extracted from mutants largely sedimented as smaller 
particles.   
 
The KI axonemal extracts from the indicated strains were sedimented through a 5-
25% sucrose density gradient and the fractions were assessed by western blots probed 
for relevant RSPs. The major peaks were indicated by arrows. The extracted RSPs 
from all truncation mutants sedimented together as intact particles smaller than WT 
RSs. A second RSP3 peak (asterisk) was present in the gradients from ∆1 and 1-178 
strains that lacked Coil 1. 
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the mutants, RSs with truncated RSP3 sedimented as smaller particles, similar to or 
smaller than RS stalk particles from the mutants lacking the head proteins (Yang et al., 
2001). While the gradients of 1-244, 1-269 and 1-316 strains contain a single RSP3 peak, 
the gradients of the ∆1 and 1-178 strains that lack Coil 1 contained another minor peak, 
suggesting that Coil 1 is critical to the unusual stability of the RS complex, possibly for 
the formation of a dimeric coiled coil.     
 
3.2.5 Electron Microscopy Reveals Distinct Dwarf RSs in RSP3 Mutant Axonemes 
To verify the hypothesis independently, the morphology of the RS with truncated RSP3 
was assessed by electron microscopy (EM). Due to the resolution of EM and the similar 
sizes of the RS particles in the mutants, we only compared the axonemes of WT, ∆1 and 
1-178 strains (Figure 3-5A). If the proposed model is correct, the two RSP3 truncation 
mutants would have shorter RSs with and without the spokehead respectively (Figure 3-
5B). 
The EM images of axoneme cross sections revealed two main defects, a lateral 
shift of the CP, a signature of prominent RS defects (Witman et al., 1978); and stubby 
RSs (Figure 3-5A and Table 3-3). Importantly, some RS stubs in ∆1 axonemes but not 1-
178 axonemes exhibited an enlarged head (Insets), consistent with the presence of head 
proteins only in the ∆1 axonemes (Figure 3-2) and the proposed model (Figure 3-5B). 
The RSs, measured to outer doublets, are the longest in the WT and the shortest in 1-178 
(Figure 3-5C). About 92% of ∆1 images and about 69% of 1-178 images had deviated CP 
(Table 3-3). The more prominent shift of the CP in ∆1 despite longer RS may be due to 
their spokeheads that could adhere and actively detract the CP off the center.  
68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3- 5. Distinct stubby spoke in the axonemes from the ∆1 and 1-178 
mutants.  
 
(A) The representative images of cross-sectioned axonemes revealed by 
transmission electron microscopy. Full length RSs on each outer doublet tug the 
central pair apparatus to the center of the WT axonemes. The RSs in the axonemes 
of ∆1 and 1-178 strains were shorter, resulting in the lateral shift of the central pair 
apparatus in some axonemes. However, only the dwarf RSs in ∆1 axonemes 
contain slightly enlarged spokehead. The bottom panel gives an enlarged view of 
the axoneme cross sections. The arrows highlight the defective radial spokes. (B) 
Schematic pictures depicting the RSs in each strain. (C) The lengths of RSs in 
cross sectioned axonemes.   
 
A B 
C 
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            n, the total number of cross-sectioned axoneme images that were visually    
inspected. 
a
  The number of axonemes with a deviation that was large enough to be 
 measured 
Strain % of axonemes 
with deviated CP 
# of Axonemes 
measureda 
% deviation of the 
CP 
WT 3.7% (n=27) - - 
∆1 92% (n=38) 
14 16.6% 
3 15% 
2 20% 
1-178 69% (n=39) 
9 16.6% 
5 20% 
Table 3-3. The incidence of lateral-shifted central pair (CP) apparatus in 
axonemes and the extent of deviation. 
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               The combined results from motility, biochemical and morphological analyses 
support the proposed model (Figure 3-1C) -- RSP3 dimer extends throughout the 
spokestalk with two discrete regions for anchoring the two types of D/D domains in four 
RSPs. A region near Coil 2 anchors the Dpy-30 domain present in RSP2 and RSP23. The 
helices downstream to the binding region in both RSP2 and RSP3 may form coiled coils 
with each other and with the head components. As for RSP23, the Dpy-30 domain could 
tether the associated NDK to the RS complex. Finally, the coiled coils adjacent to the 
docking and anchoring region in RSP2 and RSP3 associate with the spokehead (Yang et 
al., 2008). Through these multiple interactions, the head, neck and stalk are linked 
together. 
For the two RIIa-containing proteins, RSP11’s RIIa domain docks onto the AHR 
in RSP3 while its short flanking sequence tethers the ARM repeat protein (RSP8) to 
interact with the Coil 1 region in RSP3 directly or indirectly. We speculate that this may 
enhance the rigidity of the dimeric RSP3 core, since the mutants defective in RSP11 can 
swim but become paralyzed in the exhausted media (Yang and Yang, 2005). By the same 
token, RSP7’s RIIa domain docks to AHR in the other RSP3 monomer. Yet contrary to 
the constitutive function of RSP11, RSP7’s EF-hands could allosterically modulate the 
stalk when calcium increases, analogous to the cAMP-induced release of the PKA 
catalytic subunit. These various effector mechanisms of the four RSPs are all docked 
through the D/D domains to the two regions in RSP3.   
Taken together, with all these molecular interactions throughout the RS, including 
the association with the axonemal outer doublets (Diener et al., 1993), the dimeric RSP3 
clearly is a bona fide core scaffold of the entire RS complex. The effectors anchored 
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through AH-D/D domains facilitate the assembly of the rest of RSPs and modulate the 
scaffold itself in calcium-dependent and independent manner. Such a model depicts the 
RS with sufficient rigidity to mechanically couple the CP and outer doublets during 
oscillatory beating and can be modulated when calcium induces changes in oscillatory 
beating. 
There are several alternative models. For instance, each 96-nm repeat contains 
two RSs and each of the two RSPs with the same D/D domain may reside in only one RS. 
However, this model is inconsistent with the co-assembly and direct interaction of the 
Dpy-30-domain containing RSPs. RSP23 is diminished when RSP2 is diminished in the 
axoneme of RSP2 mutant pf24. Furthermore, these two molecules and their human 
counter parts, directly interact with each other in the pull-down experiments and in the 
yeast two-hybrid system (Kohno et al., 2011; Rual et al., 2005). The second possibility is 
that the RIIa clan domain containing proteins can form heterodimers. However, we have 
not succeeded in coercing the formation of hetero-dimers. Recently it was shown that 
RSPs form smaller sub-particles in the cell body of the RSP3 mutant pf14 (Diener et al., 
2011). Perhaps, homodimers of RSP2 and RSP23 form a hetero-tetramer prior to docking 
to the RSP3 dimer. Preformed sub-complexes may ensure each RS contains both RIIa-
RSPs and both Dpy-30-RSPs.  
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Section 2: In vitro approach 
Although the in vivo approach provides results with in vivo relevance, it is not possible to 
demonstrate unequivocally the direct interaction because of the inherent assembly 
mechanism of axonemal complexes in the cell body. For example, the five spokehead 
components pre-assembled as a unit (Diener et al., 2011). All five proteins are absent 
even when one protein is defective (Huang et al., 1981). Thus, to test the direct 
interaction between RSP3 and the RIIa clan domains we took an in vitro approach. In 
addition, it is possible to express small fragments of interest in vitro while in the in vivo 
setting deleting the N terminus of RSP3 which is essential for the assembly of the RS is 
not feasible (Diener et al., 1993). 
Short fragments of RSP3 were synthesized as a fusion protein with a glutathione 
S-transferase (GST) tag at the N-terminus. The GST tag was chosen for several reasons; 
to serve as a carrier that would protect the short fragment from degradation, the highly 
soluble GST tag would aid in the efficient expression of the peptides in the bacterial 
system. Furthermore, the tag would serve as a marker for the detection of the peptides.  
Lastly, its affinity to glutathione can be exploited to purify the peptides using glutathione 
agarose beads.   
Conversely, the polypeptides with the RIIa domain or the Dpy-30 domain were 
fused to a 6 His sequence for similar reasons. The affinity of the His tag for Ni2+ ion 
enables the pull-down and affinity chromatography of the fusion proteins using Ni-NTA 
matrix. To test the interaction between the peptides of interest and the RIIa or Dpy-30 
domain, a vector that encodes the GST tagged truncated RSP3 constructs was co-
transformed into bacteria along with a vector that encodes the His tagged RIIa or Dpy-30 
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domain. This system allowed us to test with either the glutathione affinity matrix or the 
nickel affinity matrix. If the two fusion proteins interact, then both molecules should be 
pulled down using either glutathione or nickel affinity matrix. In this project, Ni-NTA 
affinity matrix was primarily used. 
  
3.3 Results 
3.3.1 RSP3 Directly Interacts with RIIa domain of RSP7 and Dpy-30 Domain 
Previous studies have shown that N-terminus of RSP3 (161-178 a.a) interacts with RII 
(Gaillard et al., 2001), while RSP3 can be co-purified with RSP11 (Yang et al., 2006). 
However, perturbing this RIIa binding site did not abolish the assembly of RIIa-domain 
containing RSP7 or RSP11 (Gaillard et al, 2006). The results from the in vivo approach 
have verified that the AH sequence is used to anchor the RIIa domain in these two non-
PKA proteins. Hence we used the RIIa domain of RSP7 as an example to demonstrate the 
direct interaction between the AH and the RIIa-domain from these non-PKA proteins. 
For the Dpy-30 domain, the in vivo studies have mapped its binding sequence to a helical 
region (269-316 a.a) downstream to the RIIa-binding AH. 
Three short peptides within these two regions in RSP3 were generated, RSP396-
180, RSP3245-316 and RSP3269-316. The coding sequence for these fragments were PCR-
amplified and cloned into pGEX-2T vector, resulting in the expression of fusion proteins 
with a GST tag at the N terminus. The RIIa domain of RSP7 as well as Dpy-30 was 
cloned into pET-28a vector, resulting in the expression of a N-terminally His-tagged 
polypeptide in the case of Dpy-30 and C-terminally tagged polypeptide in the case of 
RIIa. 
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The constructs for GST-tagged RSP396-180, which contained the RIIa-binding AH 
at a.a.#161-178 a.a, and for the His-tagged RIIa were co-transformed into BL21(DE3) 
cells. The transformants were screened by double selection using culture plates that 
contained both carbenicillin (pGEX-2T) and kanamycin (pET-28a). The surviving clones 
were cultured and the proteins were induced by IPTG. As predicted, GST-tagged RSP396-
180 was co-purified with the His-tagged RIIa domain by Ni-NTA (Figure 3-6A). This 
result served as a positive control and confirmed the interaction between the AH (161-
178 a.a) and the RIIa domain. 
The Dpy-30 domain containing RSPs, RSP2 and RSP23, were not amenable for this 
study due to their tendency to precipitate. Hence human Dpy-30 protein was co-
expressed with RSP3 polypeptides. The human Dpy-30 protein was cloned into pET-28a 
vector which resulted in a His-tagged polypeptide. GST-tagged RSP3245-316 and RSP3269-
316 were co-transformed into BL21(DE3) cells along with His-tagged human Dpy-30 
protein. The transformants were induced with IPTG overnight at 16°C. The His-tagged 
human Dpy-30 proteins were pulled down using nickel beads. The samples which 
included ‘pre’, ‘post’ and the ‘elute’ were fractionated on SDS PAGE gels and visualized 
by Coomassie staining. Both RSP3245-316 and RSP3269-316 were pulled down along with 
human Dpy-30 protein (Figure 3-6 B and C). This result confirms the direct interaction 
between the candidate region (269-316 a.a) and human Dpy-30 protein. As a negative 
control, pGEX-4T vector with no insert was also co-expressed with human Dpy-30 
protein to demonstrate that GST tag on its own does not interact with human Dpy-30 
protein (Figure 3-6 D). 
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Figure 3-6. Two regions in RSP3 bind to the RIIa and the Dpy-30 domain 
in vitro.  
 
(A) His-tagged RIIa from RSP7 (asterisk) or His-tagged Dpy-30 protein 
(arrowhead) were co-expressed with a RSP3 peptide tagged to GST (dot). The 
Ni-NTA pull-down was analyzed by Coomassie stained protein gel. (A) The 
positive control, the co-purification of the RIIa domain and the 96-180 fragment 
containing the RIIa-binding AH (Gaillard, 2001). (B) and (C) The co-
purification of Dpy-30 protein and GST tagged RSP3 fragments (dot). (D) The 
negative control, showing that GST alone does not interact with Dpy-30 protein. 
Pre, the bacterial extract; Post, the flow through from Ni-NTA matrix; and E, 
the eluate. 
 
A B C D 
76 
 
 
These co-expression studies provided evidence for the direct interaction of the 
AH with the RIIa domain and RSP3269-316 with the Dpy-30 protein. 
 
3.3.2 Defining the Dpy-30 Domain Binding Site 
In order to compare the binding sites of the RIIa clan domains we defined the exact Dpy-
30 binding site within 269-316 a.a. Smaller constructs were engineered that expressed 
different regions within 269-316 a.a. All the RSP3 polypeptides were tagged with GST at 
the N terminus and cloned into the pET-Duet vector. The GST tagged RSP3 polypeptides 
were co-expressed in BL21(DE3) cells along with His-tagged human Dpy-30 protein. 
The human Dpy-30 protein was subjected to affinity purification and pulled down using 
Ni2+ beads. The samples which included the ‘pre’, ‘post’ and the ‘elute’ were fractionated 
on SDS PAGE gels and RSP3 polypeptides were detected using the α-GST antibody. 
RSP3280-316 and RSP3280-308 were effectively pulled down by human Dpy-30 protein 
(Figure 3-7). RSP3280-306 however was not able to pull-down human Dpy-30 protein 
(Figure 3-7). Thus the Dpy-30 protein binding site was narrowed to the 28 a.a. region 
between #280-308. 
AKAPs interact with the RIIa domain through a 14-18 residue amphipathic helix 
(Carr et al., 1991). Hence the 18 residue RIIa domain binding site in RSP3 (161-178 a.a) 
forms an amphipathic helix. Previous studies have shown that when the amphipathic 
helix is disrupted by introducing point mutations, the binding with the RIIa domain is 
abrogated (Carr et al., 1992; Gaillard et al., 2001). We speculate that the other member of  
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Figure 3-7. The Dpy-30 protein binds to a.a.# 280-308 in RSP3.  
 
His-tagged full-length Dpy-30 protein was co-expressed with GST-tagged 
RSP3 peptides and then subjected to Ni-NTA pull-down. The protein 
samples fractionated by SDS-PAGE were probed for GST. The smallest 
region that bound the Dpy-30 protein was a.a. # 280-308. The interaction was 
perturbed by V300P mutation. Pre, the bacterial extract; Post, the flow through 
from Ni-NTA matrix; and E, the eluate. 
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the RIIa clan, Dpy-30 domain would also bind to similar amphipathic helices. Thus 
creating point mutations within the Dpy-30 binding site that disrupt the helicity of the 
region should abrogate its binding with the Dpy-30 domain. To test this we generated 
RSP3280-316 polypeptide that contained a point mutation which replaced valine at 300 with 
a proline. The RSP3 polypeptide containing the mutation was cloned into the pET-Duet 
vector. The vector containing mutated RSP3 protein was transformed into BL21-DE3 
cells along with His tagged human Dpy-30 protein. The transformants were expressed 
and subjected to affinity purification (as described before). The mutated RSP3 
polypeptide was not able to pull-down human Dpy-30 protein (Figure 3-7). This suggests 
that the binding principles of both the RIIa clan domains are very similar. 
 
3.3.3. Dpy-30 Protein Interacts with RSP3 through the Dpy-30 Domain 
The co-expression studies were carried out with full length human Dpy-30 protein. 
However, Dpy-30 protein is 99 amino acids in length. In addition to the 40 a.a. Dpy-30 
domain in its C terminus, it has 59 additional residues. To clarify that the interaction 
between RSP3 polypeptides and the human Dpy-30 protein occurred through the 40 a.a. 
Dpy-30 domain, we engineered a construct that expresses the Dpy-30 domain alone. This 
construct (Dpy-3045-99) was cloned into the pET-28a vector resulting in a His tagged 
protein. Dpy-3045-99 was co-transformed into BL21(DE3) cells along with the GST-
tagged RSP3 constructs. The transformants were subjected to affinity purification using 
Ni-NTA matrix. The ‘pre’, ’post’ and ‘elute; samples were fractionated on SDS PAGE 
gels and detected by probing with α-GST antibody. As anticipated the results obtained 
using full length human Dpy-30 protein were replicated using Dpy-3045-99 (Figure 3-8).  
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Figure 3-8. The Dpy-30 domain binds to a.a.# 280-308 in RSP3. 
 
His-tagged Dpy-30 domain was co-expressed with GST-tagged RSP3 peptides 
and then subjected to Ni-NTA pull-down. The protein samples fractionated by 
SDS-PAGE were probed for GST. The smallest region that bound the Dpy-30 
domain is a.a. # 280-308. The interaction was perturbed by V300P mutation. Pre, 
the bacterial extract; Post, the flow through from Ni-NTA matrix; and E, the 
eluate. 
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This suggests that the interaction between RSP3 polypeptides and the human Dpy-30 
protein occurs through the Dpy-30 domain. Thus the co-expression studies allowed us to 
narrow down the Dpy-30 binding site to 28 a.a between residues 280 and 308 and also 
demonstrate that the binding principle of both the RIIa clan domains is highly similar. 
 
3.3.4 Construction of a Dpy-30/RSP2 Hybrid Molecule 
The low expression and precipitation propensity of RSP2 and RSP23 precludes their 
usage in co-purification experiments. We speculate that these problems can be overcome 
by creating a hybrid molecule, using the N-terminal half of the Dpy-30 protein to carry 
RSP2’s Dpy-30 domain. The hybrid molecule might remain soluble and could be used to 
test if the RSP2’s Dpy-30 domain can bind to the partner sequence in RSP3. 
 Swapping the Dpy-30 domain in these two molecules is not straightforward, since 
the domain is at opposite positions in these two molecules. For RSP2, it is located in the 
N-terminus. For Dpy-30 protein, it is located at the C-terminus. The N-terminal region 
(1-45 a.a) of Dpy-30 protein and the Dpy-30 domain of RSP2 were PCR-amplified and 
cloned into pET-28a vector. The final construct would express a His-tagged hybrid 
polypeptide including the first 45 a.a. residues from the N-terminus of Dpy-30 protein 
preceding RSP2’s Dpy-30 domain. To test its interaction with the RSP3 sequence, the 
hybrid construct was subjected to co-expression and co-purification with the GST-
RSP3280-308 construct.   
While the hybrid did bind RSP3280-308, its binding efficiency was poorer than that  
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Figure 3-9. The Dpy-30 binding domain (RSP3280-308) binds to the hybrid 
molecule albeit with low affinity. 
 
His-tagged hybrid construct which contains the Dpy-30 domain of RSP2 was 
co-expressed with GST tagged RSP3 polypeptides and subjected to Ni-NTA 
pull-down. The samples were fractionated on SDS –PAGE gels and probed for 
GST. The Dpy-30 binding region was pulled down by the hybrid construct 
while the construct harboring the point mutation was not co-purified. ‘Pre’ the 
bacterial extract, ‘Post’ the flowthrough from Ni-NTA matrix, ‘E’ the eluate. 
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of Dpy-30 protein (Figure 3-9). However, the binding was even poorer when GST-
RSP3280-308 was co-expressed with the V300P mutation construct (Figure 3-9). This 
suggests that RSP2’s Dpy-30 domain binds RSP3280-308, albeit with low affinity.  
Although, the hybrid protein allowed us to circumvent the solubility and 
expression problems of the RSP2 polypeptide, its affinity for RSP3280-308 was not as high 
as that of Dpy-30 protein. This lesser efficiency could be attributed to the tethered 
sequence in RSP2. The last helix in RSP2’s Dpy-30 domain forms a continuous helix of 
coiled coil propensity with flanking sequence. In engineering the hybrid construct this 
continuous helix was perturbed and may account for the low binding affinity of the 
hybrid construct. Additionally, recent studies on RIIa domains have shown that the 
sequences outside the domain do participate and contribute to the specificity and affinity 
of binding (Christian et al., 2011). In the same vein, utilizing the Dpy-30 domain of RSP2 
without the downstream flanking sequence could severely compromise the binding 
affinity. 
 
3.3.5 Comparing the RIIa Clan Domains 
Sequence alignment of RIIa and Dpy-30 domains from different proteins showed that 
there is considerable similarity between these domains (Figure 3-10). Both of the 
domains adopt a helix-loop-helix morphology. The RIIa domain structure is described as 
a X-shaped four helix bundle. It consists of two helix-loop-helix monomers that dimerize 
to form a hydrophobic groove to which the amphipathic helix of AKAP binds (Figure 3-
11 A) (Newlon et al., 2001; Gold et al., 2006). The N terminus of the RIIa domain of RII-
PKA is considered to be disordered and has been shown to form key contacts with  
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Dpy-30 
KAD7_HUMAN/679-720   PLRNYLMTYVMPTLIQGLNECCNVRPE----DPVDFLAEYLFKNNP---  
NDK5_HUMAN/156-197   AAKDYLNLHIMPTLLEGLTELCKQKPA----DPLIWLADWLLKNNP---  
DPY-30_HUMAN/52-93   PTRAYLDQTVVPILLQGLAVLAKERPP----NPIEFLASYLLKNKA---  
DPY30_CAEEL/69-110   PTRQYLDSTVVPILLQGLGALAKDRPE----NPIEFLANFLLREKD---  
RSP2_CHLRE/8-49      HDTAYLKETVGEALARGCAAAISAQPN----DPVEYLGLWLLKYVK---  
RSP23_CHLRE/152-197  AAAEYITKRIQPALAKALAALAREKPSADKFEAITFVAGYLLQNNP---  
 
RIIa (RI) 
Q17QF5_BOVINE/25-62  -------RGIQQVLKDCIVQLCLAKPE----RPMRFLREHFERLEKEEN  
KAP1_RAT/25-62       -------HGIQQVLKECIVHLCVAKPD----RPLRFLREHFEKLEKEEN  
A6YCE2_HUMAN/25-60   -------HNIQALLKDSIVQLCTARPE----RPMAFLREYFERLEKP--  
Q96P62_HUMAN/25-59   -------HNIQALLKDSIVQLCTARPE----RPMAFLREYFERLEK---  
A2AI69_MOUSE/25-62   -------HNIQALLKDSIVQLCTTRPE----RPMAFLREYFERLEKEEA  
 
RIIa (RII) 
KAP2_HUMAN/8-45      -------PGLTELLQGYTVEVLRQQPP----DLVEFAVEYFTRLREARA  
KAP2_MOUSE/8-44      -------PGLTELLQGYTVEVG-QQPP----DLVDFAVEYFTRLREARR  
Q6NW93_ZEFSH/7-44    -------AGLPELLRGFTLEVLRRQPA----DLLEFSVRYFTGLRDTRS  
RSP11_CHLRE/16-50    ------PHNLADILKAYTKEVIRRQPT----DLIAFSAKYFTNLAN---  
RSP7_CHLRE/13-50     -------EGFPQLLKAFTREILRNQPD----NIYEFGAKYFEDLIEENK  
CABYR_HUMAN/12-49    -------YGLKTLLEGISRAVLKTNPS----NINQFAAAYFQELTMYRG  
 
 
Helix I Loop Helix II 
Figure 3-10. Sequence Alignment of the RIIa clan domains. 
 
Sequence alignment displays the similarities between the RIIa clan domains from 
various molecules. The regions forming helix-loop-helix structures are underlined. 
The conserved hydrophobic residues and prolines are highlighted. Accession 
numbers for Dpy-30 domain proteins: KAD7 (Q96M32), NDK5 (P56597), DPY-30 
Human (NP_115963), DPY-30 C.e. (NP_506058), RSP2 (XP_001702718.1), 
RSP23 (XP_001698136). Accession numbers for RIIa (RI) domains: KAP1 
(P81377), A6YCE2, Q96P62, A2AI69. Accession numbers for RIIa (RII) domains: 
KAP2 Human (P13861), KAP2 Mouse (P12367), RSP11 (ABC02022), RSP7 
(ABC02026), CABYR (NP_036321). 
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Figure 3-11. Comparison of crystallographic structures of the Dpy-30 domain 
and the RIIa domains from PKA. 
 
(A) The domain from RII (PDB ID: 2HWN). (B) The domain from human Dpy-30 
protein (PDB ID: 3G36). (C) and (D) The alignment of the Dpy-30 domain (blue) 
with the RIIa domain (pink) from RII and RI (PDB ID: 3IM4) respectively.  
 
A B 
C D 
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residues in AKAP (Kinderman et al, 2006). The RIIa domain of RI-PKA also adopts a X-  
shaped four helix bundle like structure. The hydrophobic groove that binds AKAP is 
created by the dimerization of two helix loop helix dimers (Banky et al., 2003; Sarma et 
al., 2010). The N terminus of the RIIa domain of RI-PKA differs from the RIIa domain of 
RII-PKA. It consists of key di-sulphide bridges that are essential for the dimerization of 
the domain. The RIIa domain of RI-PKA also contains an extended N terminus that folds 
inward resulting in a binding pocket that is much deeper than the RIIa domain of RII-
PKA. It is speculated that the binding pocket of RI-PKA can accommodate bulky and 
aromatic residues unlike the flat hydrophobic groove of RII-PKA (Sarma et al., 2010). 
The Dpy-30 domain structure is also described as a X-shaped four helix bundle. It 
also consists of two helix-loop-helix monomers that dimerize to form a groove or binding 
pocket (Wang et al., 2009) (Figure 3-11 B). This groove is primarily hydrophobic in 
nature. The structure of Dpy-30 in complex with its binding partner has not been solved; 
hence it is not known how the interacting protein occupies this hydrophobic groove. But 
drawing on analogies to the RIIa domain structure, it is reasonable to speculate that the 
interaction between Dpy-30 domain and its binding partner would be very similar to the 
interaction between RIIa domain and AKAP.  
To compare the Dpy-30 domain and the RIIa domain of RI and RII-PKA, the 
structures were aligned using PyMOL (Figure 3-11 C and D). The alignment showed that 
although the core structure of the RIIa clan domains is similar, the Dpy-30 domain is 
more similar to the RIIa domain of RI-PKA (Figure 3-11 D). Like the RIIa domain of RI-
PKA, the N terminal region of Dpy-30 domain also contains an extended helix that fold 
inwards resulting in a deeper binding pocket. The binding pocket of the Dpy-30 domain 
86 
 
 
has been described as less flat and less hydrophobic compared to the RIIa domain of RII-
PKA (Wang et al., 2009). These differences may be key to afford specificity to these 
domains. Thus the RIIa clan domains exhibit several similarities and a few key 
differences.  
 
3.3.6 Comparing the RIIa Clan Domain Binding Sites 
The similarities between the RIIa clan domains led us to compare the RIIa clan domain 
binding sites from various proteins in various organisms. The binding sites of RIIa clan 
domains were analyzed using helical wheel programs. The binding sites formed 
amphipathic helices with a distinctly hydrophobic face and a hydrophilic face. The 
amphipathic nature of RIIa domain binding sites is a well-documented finding. But the 
finding that this feature is also shared by Dpy-30 domain binding sites is novel (Figure 3-
12 B). This finding reinforces the similarity in the binding principle of these domains. 
Sequence comparison of RIIa and Dpy-30 domain binding sites did not reveal 
considerable identity. But when examined closer, it revealed conservation in the pattern 
of the sequences. Analyzing the RIIa and Dpy-30 binding sites from different proteins in 
different organisms we found that these binding sites contained hydrophobic residues that 
repeat in pairs interspersed by non-hydrophobic residues (Figure 3-12 A). These repeats 
were designated as ‘hydrophobic dyads’. Some binding sites contained four such pairs 
while some contained three pairs. This difference in number of pairs could depend on the 
number of contacts the binding peptide makes with the RIIa clan domains. Previous 
studies have shown that such a difference exists in the interaction between dual AKAP 
(AKAP that interacts with the RIIa domain of both RI-PKA and RII-PKA) and the RIIa  
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Figure 3-12. Similarities of the RIIa- and Dpy-30-domain binding sequences.  
 
(A) Alignment of RSP3 sequences with the amphipathic helices that bind RIIa- (AHR) or 
Dpy-30-domain (AHD). Paired hydrophobic residues (black boxes) alternate with two varied 
residues. No particular residues are conserved to distinguish the two groups of sequences. 
D-AKAP2, a dual specific AKAP that binds the RIIa domain in RI and RII of PKA. Ash2 
and BIG1, the Dpy-30-binding protein in histone methyltransferase complex and in the 
trans-Golgi network. RII-AKAP, Q12802; RI-AKAP, AAC24507 ; C.r., Chlamydomonas 
reinhardtii; C.e., Caenorhabditis elegans; D.r., Danio rerio; H.s., Homo sapiens; S.c., 
Saccharomyces cerevisiae. (B) Helical wheel plots of the sequences. The hydrophobic 
residues (bold and circled) are clustered to one side of the helix as expected for an 
amphipathic helix. AHR and AHD, the RIIa- and Dpy-30-binding sequences in RSP3. 
 
A 
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domain of RI-PKA and RII-PKA. The crystal structures of both these complexes revealed 
that the same peptide undergoes one whole helical turn to bind the RIIa domain of RI-
PKA (Sarma et al., 2010). Thus, in turn, the peptide makes more contacts with residues in 
the RIIa domain of RI-PKA.  
The binding sites of RIIa domain from RII-PKA and RI-PKA have been studied 
extensively. These studies have shortlisted certain key residues that make a binding site 
specific for RII-PKA or RI-PKA (Banky et al., 2003; Sarma et al., 2010). In the same 
line, the Dpy-30 domain is not well studied and very few Dpy-30 domain binding sites 
have been characterized. Thus, it is difficult to compare the Dpy-30 binding sites with the 
RIIa binding sites and establish differences between these two domains.  
The bioinformatics analysis revealed that similarities exist not just between the 
RIIa clan domains but also between the RIIa clan domain binding sites. This establishes 
the common binding principle behind these domains. Utilizing a common binding 
principle might stem from a common function of these domains which we speculate is 
targeting proteins to the appropriate location. 
 
3.4 Discussion 
The truncation strategies, using both the in vivo and the in vitro system, reveal the 
distinct binding sites for the RIIa and Dpy-30 domain in the RS. These distinct sites are 
amphipathic in nature, like all RIIa binding sites within AKAPs. In addition, the mutant 
phenotypes from the in vivo system also reveal the molecular interactions of the 
sequences tethered to these two domains. These findings elucidate the topology of the RS 
and explain the operational mechanism of this complex central for the motility control. In 
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addition, the results from the in vitro approach also revealed the common binding 
principle for anchoring the similar RIIa and Dpy-30 domains. The evidence and 
conclusions from this study are summarized below. The implications of these findings 
will be discussed in detail in the final chapter.  
 
3.4.1 RSP3 Contains Binding Sites for the RIIa and Dpy-30 Domain  
The in vivo approach which involved generating RSP3 truncation mutants in 
Chlamydomonas was utilized to test if RSP3 could directly interact with all four RSPs 
with either a RIIa or Dpy-30 domain. The complementary phenotypes of the strains 
lacking major parts of RSP3 in the (∆1) and 1-178 strains support this prediction. The 
analysis of the truncation mutants also revealed several details pertinent to the 
organization of the RS complex. It confirmed that the two RIIa RSPs, RSP7 and RSP11, 
are anchored through the AH that is known to anchor RII in vitro (Gaillard et al., 2001; 
Yang and Yang, 2006). This showed that these RIIa domains, identified based on 
sequence analysis, are functionally equivalent and are used for various molecules, aside 
from PKA. In the same token, this could be applicable to the Dpy-30 domain. 
Furthermore, the deficiency of armadillo repeat protein, RSP8 (ARM) that interacts with 
RSP11, in the ∆1 strain suggests that ARM associates with the coil 1 region of RSP3 
either directly or through RSP11. These findings indicate that RSP11, RSP8 and RSP3 
may form a tri-molecular complex. Most importantly, these results also suggest that the 
interaction between the AH and RSP11 tethers the ARM to RS complex and hence 
structurally reinforces the spoke scaffold. The deficiency of RSP7 in the ∆1 strain is 
identical to RSP11. Thus these two RIIa proteins are assembled similarly. We speculate 
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that RSP7 functions to tether the second ARM-containing RSP, RSP14. However, we 
could not verify this prediction due to lack of appropriate antibodies.   
Lastly, these results also predicted that the candidate binding site for Dpy-30 
domain should be downstream to the AH. Based on the mutants expressing RSP3 varying 
at the C-terminus, the Dpy-30 binding region was further delimited to be ~50 a.a. near the 
end of the conserved region in RSP3. Furthermore, the spokehead deficiency observed in 
these RSP3 truncation mutants is similar to the RSP2 mutants (Huang et al, 1981; Patel-
King et al., 2004). This indicates that RSP3 collaborates with RSP2 in linking the 
spokehead to the stalk. This confirmed the prediction that RSP2 is not the only molecule 
connecting the head and stalk modules together. These predictions were strengthened by 
EM of the RS in truncated RSP3 mutants. Together, these findings provide the evidence 
for establishing the topography of the RS.    
   
3.4.2 The Topography of the RS 
These results combined with the previous finding that RSP3 N-terminus is anchored to 
the outer doublets (Diener et al., 1993), support a model wherein dimeric RSP3 forms the 
scaffold of the RS complex. The two AHs in each RSP3 monomer anchor a protein with 
a RIIa domain and a Dpy-30 domain respectively. This model predicts the topology of 
the RS complex which couples the CP to the dynein motors on the outer doublets. 
The dimeric core from a single protein extending throughout the RS provides the 
backbone to build a rigid complex. Docking of the RIIa domain at the AH at a.a.# 161-
178 localizes within the RS complex the flanking sequences in RSP7 and RSP11 and the 
associated ARM RSPs. These tethered modules could possibly modulate or strengthen 
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the rigidity or other physical properties of the RS for appropriate mechanical transduction 
under a wide range of conditions. The docking of the Dpy-30 domain at the downstream 
AH at a.a.#280-308 enables the flanking coils in both RSP3 and RSP2 to interact with 
each other and to harness the multiple components in the spoke head and spokeneck.   
These multiple molecular interactions may be necessary to forge the two modules into 
one object that contacts the CP and endures the intermittent force occurring repeatedly 
from the mechanical transduction between the CP and the RS. The dimeric nature of 
RSP2 and RSP3 (Wirschell et al., 2008) makes it possible to form a symmetric spokehead 
that tilts back and forth around the circumference or along the length of the axonemes 
during each oscillatory beating. In addition, the docking also localizes the NDK in RSP23 
to the neck. The localization of NDK at this position is unclear. However, it seems to be a 
valuable strategy since this molecule is also present in mammals. One possibility is that 
RS is a measure to distribute the NDK enzyme that balances the concentrations of ATP 
and GTP evenly throughout the flagellum. Or the enzymatic activity serves to solely 
regulate motility by modulating the local function of the RS or RS/CP system.   
 
3.4.3 The In Vitro System Identified the RIIa- and Dpy-30 Binding Sequence. 
Using the in vitro approach, it was possible to confirm that the AH in RSP3 binds the 
RIIa domain from RII, RSP7 and RSP11. Most importantly, it also defined the precise 
Dpy-30 binding site from the 50-a.a. region as revealed in the Chlamydomonas RSP3 
mutants. The Dpy-30 protein from human histone methyltransferase complex helped 
circumvent the solubility issues encountered with RSP2 and RSP23 in this system. The 
results are justified, as the AHR that was shown to bind recombinant RIIa domain in vitro 
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(Gaillard et al., 2001) also bound the RIIa domain of RSP7 and RSP11 (Yang et al., 
2006). The AH for Dpy-30 domains were further confirmed by the V300P mutation.  
  
3.4.4 The Comparison of the RIIa and Dpy-30 Binding Sequences 
The well-defined binding sites made it possible to compare the binding sequences for the 
RIIa and Dpy-30 domains. The two RSP3 peptide sequences for binding RIIa and Dpy-30 
domain were significantly different from each other and from other representative 
proteins. However sequence alignment showed that they do follow an identical pattern, 
repeats of ΦΦXX, twin hydrophobic residues (ΦΦ) interspersed by paired variable a.a.. 
Furthermore, the Dpy-30-domain binding helix can be plotted into an AH in a pattern 
similar to the RIIa binding sequences. This similar AH pattern is echoed by the similarity 
between the Dpy-30 domain and RIIa domain from both RI and RII. Thus, it is rather 
interesting that, although the two domains bind to RSP3, especially at two distinct sites, 
the principle of the interaction is quite similar if not identical.  
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Chapter 4: Development of tools for the study of Dpy-30-
anchoring mechanism 
 
4.1 Introduction 
This thesis and recent findings have demonstrated the similarities of the Dpy-30 and RIIa 
domain in sequence, structure and function (Chapter 3). Each domain is present in over 
200 molecules that have additional diverged molecular architectures. These molecules 
mediate vital processes ranging from flagellar motility to membrane trafficking to 
epigenetic regulation. Like RII that binds many AKAPs, Dpy-30 protein itself binds to at 
least two vital molecules, BIG1 in the Golgi apparatus and Ash2 in histone 
methyltransferase complexes in the nucleus (Xu et al., 2009; Cho et al., 2007). The 
binding of human Dpy-30 protein to the Dpy-30-domain-binding AH in the radial spoke 
(RS) demonstrated the functional equivalence of these domains. Collectively, these 
findings raise three important questions. First of all, do the RIIa and Dpy-30 domains 
demonstrate specificity in terms of their binding partners? Secondly, aside from BIG1 
and Ash2, how many more molecules anchor Dpy-30 proteins in various cells and 
organisms? Lastly, could the new findings on the Dpy-30 domain be applied for other 
research and therapy, such as the identification or perturbation of other anchoring 
proteins?   
Similar questions have been thoroughly explored for the RIIa domain, cAMP-
dependent protein kinase A (PKA) and numerous A-kinase anchoring proteins (AKAPs). 
The explosive discoveries in this field heavily relied on several powerful tools. The 
development of the labeled RII, a high-affinity blocking AH and the RII overlay 
catapulted the study of AKAPs and the differential targeting of RI type PKA and RII type 
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PKA. Similar tools for the Dpy-30 domain will likely simplify and accelerate the research 
of this domain and its anchoring proteins.  
This dissertation has highlighted the insight that could be gained from exploring 
the anchoring proteins of Dpy-30 domain. As described in Chapter 3, identification of 
RSP3 as the anchoring protein for the Dpy-30-domain-containing RSP2 and RSP23 led to 
the elucidation of the molecular topography and mechanism of the RS. The reagents 
designed for these experiments could be modified into new tools towards understanding 
the Dpy-30 proteins and its molecular interactions.  
Initially, recombinant human Dpy-30 and the RIIa domain that bind to the 
respective GST-tagged AHs could be used to test cross reactivity and to design the first-
generation overlay assay. Subsequently, the existing constructs could be modified by 
adding different tags depending on the requirement of each assay. Each assay has distinct 
advantages and some of these assays need to be sensitive and quantitative. These new 
tools will pave the way for the development of specific and high affinity blocking AHs. 
The preliminary data for these assays will be described in this chapter.  
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4.2 Results 
The ultimate goal is to develop simple assays for identifying various proteins that anchor 
the Dpy-30 domain and high affinity AHs that block the interaction. These two goals are 
related. Simple assays will help the development of high affinity AHs. Conversely, high 
affinity AHs can verify the specificity of the interaction between the anchoring proteins 
and Dpy-30 in the assays. Studies on the Chlamydomonas flagellar RS complex 
described in Chapter 3 defined the RIIa and Dpy-30 binding AH in RSP3. These results 
were exploited to establish three strategies described below. 
  
4.2.1 Strategies to Identify Dpy-30 Interacting Polypeptides 
Three strategies were taken to identify Dpy-30 interacting polypeptides: affinity co-
purification, native gel electrophoresis; and a Dpy-30 overlay. All three methods can be 
used to test candidate Dpy-30 binding polypeptides. The overlay can be used to screen 
unknown samples. 
 
4.2.1.1 Affinity Co-Purification 
This method relies on the interaction of two recombinant proteins that are co-expressed in 
bacteria; or expressed separately but mixed together once bacteria are lysed. This method 
has been used extensively in the study for PKA and AKAPs (Carr and Scott, 1992) and in 
this dissertation to identify the RIIa and Dpy-30 binding sites in RSP3. Specifically, His-
tagged RIIa clan proteins and GST-tagged RSP3 peptides were co-expressed in bacteria 
and were pulled down together by Ni-NTA affinity chromatography. Alternatively, they 
could also be pulled 
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Figure 4-1. The Dpy-30 domain cross-reacts with the AHR. 
 
(A) His-tagged Dpy-30 protein (arrowhead) or (B) His-tagged RIIa domain 
from RSP7 (arrowhead) were co-expressed with GST tagged AHR or AHD 
respectively (dot). The Ni-NTA pull-down was analyzed by Coomassie 
stained protein gel. While the AHR (dot in A) cross-reacted with the Dpy-30 
protein, the AHD (dot in B) did not bind to the RIIa domain from RSP7. Pre, 
the bacterial extract; Post, the flow through from Ni-NTA matrix; and E, the 
eluate. 
A B 
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down by glutathione-agarose that binds GST. The reciprocal co-purification of the GST-
tagged RSP3 peptides along with the His-tagged RIIa clan proteins indicate the ability of 
these two proteins to interact.  
 To test if the two sets of AHs and the RIIa clan domains cross-react, His-tagged 
Dpy-30 and GST-tagged AHR were co-expressed in bacteria. Although AHR binds the 
RIIa domain in vivo, it also co-purified with Dpy-30 (Figure 4-1A). This indicates the 
similarity and the identical binding principles of these two domains. However, the cross 
recognition is not universal, since it was not observed in the reverse experiments. The 
RIIa domain from RSP7 was not pulled down by the GST-tagged AHD that binds Dpy-30 
domain in vivo (Figure 4-1B). The selective cross reactivity is interesting. One possibility 
is that certain AHs or RIIa clan domains have broad recognition because of their amino 
acid residues. Alternatively, the cross recognition may be due to the contour of the 
binding surfaces. The binding cavity in the dimeric RIIa domain tends to be shallower 
than the Dpy-30 domain and RI’s RIIa domain.  
This experimental strategy allows us to test the interaction between various 
combinations of anchoring proteins and docking domains.  
 
4.2.1.2 Native Gel Electrophoresis 
The disadvantage of the pull-down assay is that the two proteins to be tested must have 
different tags. This limitation could be circumvented by native gel electrophoresis that 
fractionates protein complexes and is tag-independent. However, the two proteins to be 
tested need to be purified.      
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To test the principle, Dpy-30 protein was mixed with the two AHs in RSP3: AHR 
at a.a.# 161-178, that interacts with the RIIa domain in vivo; and AHD  at a.a.# 280-308, 
that binds to the Dpy-30 domain in vivo. Both AHs were tagged with GST. Also tested 
was a peptide within the Dpy-30-binding sequence in Ash2, the physiological partner of 
Dpy-30 protein in the Set-1 methyl transferase complex (South et al., 2010). The peptide 
was predicted based on its secondary structure and three units of ФФXX that is typical of 
the RIIa-clan- binding AHs. Ash2 peptide was tagged with GFP and a His tag at the N 
terminus. The advantage of GFP is its monomeric nature while GST is inherently 
dimeric. Secondly, GFP fluoresces and this fluorescence can be used as a reporter for a 
one-step quantitative assay. However, GFP is not conducive for affinity purification 
hence a second tag, 8 His in this case, was added for affinity purification.   
His-tagged Dpy-30 and His-tagged GFP-Ash2-AHD proteins were purified using 
Ni-NTA. The GST-RSP3-AHD polypeptides were purified using glutathione-agarose.  
Equal amounts of each tagged AH and purified Dpy-30 were mixed together. Following 
1-hour incubation, the samples were fractionated on a native gel and visualized by 
Coomassie stain (Figure 4-2). As protein complexes remain intact in native gels, an 
interaction between Dpy-30 and tagged AH would result in a shift in the band size as 
compared to the control samples that contained only one protein.  
The results showed that all mixtures contained new bands distinct from the bands 
of the individual molecules (Figure 4-2). This showed that Dpy-30 forms a complex with 
AHD at RSP3280-308 as expected and with the predicted AHD in Ash2. This is the third line 
of evidence that the Dpy-30-binding sequences contain triple or quadruple units of 
ФФXX a.a., just like the RIIa-binding sequences. In addition, Dpy-30 also binds to AHR 
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that binds the RIIa domain, as shown in the pull-down assay (Figure 4-1A). Thus this 
method and the pull-down assay are suitable to test the interaction between anchoring 
motifs and docking domains. 
Notably, Dpy-30 band shifts in opposite directions when complexed with GST-
tagged or GFP-tagged AHD. When Dpy-30 is allowed to interact with the AH tagged to 
GST that is a dimer, the Dpy-30 oligomers become smaller, slightly bigger than GST 
tagged-AHs. In contrast, Dpy-30 actually shifted upwards when it forms complex with 
Ash2-AHD that is tagged to the monomeric GFP.  
The opposite shifting directions could be due to the differences in tags or AHD.  
Although Dpy-30 is assumed to function as a dimer, purified Dpy-30 domain forms 
tetramers and higher-ordered oligomers (Dong et al., 2005; Wang et al., 2009). Dimeric 
GST-tagged AHs may dissociate Dpy-30 oligomers into dimers. The dimeric tag could 
potentially influence the kinetics of the molecular interaction. To test this, the native gel 
assay could be conducted to compare two fusion proteins with the same AHD but tagged 
to GFP or GST.  
In summary, native gel electrophoresis is a rather straight forward assay for 
testing the interaction between purified Dpy-30 and candidate target proteins. The 
resolution of monomers and complex depends on the band shift. However, the shift in 
this case is sufficient and the method is easy and economical. However, the migration 
patterns could be influenced by tags and hence it is important to use the same tag when 
comparing the kinetics of different AHs for Dpy-30. 
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Figure 4-2.  Native gel electrophoresis for identifying Dpy-30-binding 
peptides. 
 
GFP-tagged Ash2 and GST-tagged RSP3 peptides purified from bacteria were 
mixed with purified Dpy-30 protein (dot represents the tetramer) and fractionated 
on a native gel. AH, amphipathic helix; D, Dpy-30 binding AH in RSP3; R, RIIa-
binding AH in RSP3. Polypeptides were revealed by Coomassie stain.  
 
 
. 
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4.2.1.3 Overlay 
Compared to the previous two assays, overlay is extraordinarily simple and versatile. It is 
analogous to a far western assay. Both use a protein ligand as a probe to detect its binding 
partners on the blot. The ligand can be labeled, for example with radioisotope, biotin or 
enzymes to aid in the detection. Or the ligand, as in far western assays, could be 
visualized indirectly through antibodies. These methods have been used successfully to 
study the interaction between RII and AKAPs (Lohmann et al., 1984).  
In particular, 32P-labeled RII was often used as a ligand to identify AKAPs in 
different biological systems. The protein samples are separated on SDS-PAGE gels and 
transferred to a nitrocellulose membrane. Subsequently the membrane is probed with 32P-
labled RII and the AKAP bands are revealed by autoradiography or a phosphorimager. 
The ligands can recognize other non-AKAP bands as well. In order to identify AKAPs 
that interact with RII through the AH and RIIa domain, the control experiment is carried 
out in the presence of Ht-31, a synthetic peptide derived from the AH of AKAP-Lbc. 
This peptide has a high affinity for RII and acts as a competitive inhibitor. In theory, a 
protein that binds RII in an AKAP specific manner will not bind to RII in the presence of 
Ht-31.  
We have tested an overlay, in fact a far western assay, using Dpy-30 as the ligand.  
In theory, this assay would aid the identification of Dpy-30 binding proteins in various 
protein samples (Figure 4-3). Axonemes from WT and spokeless pf14 strains were 
fractionated in an SDS PAGE gel and transferred onto a nitrocellulose membrane (Figure 
4-4A). The membrane was probed with 1 µg/ml purified Dpy-30 protein. The blot was 
then probed with α-Dpy-30 antibody followed by the secondary antibody. The assay 
102 
 
 
revealed a band which was present in WT axonemes but absent in pf14 (Figure 4-4A). 
This suggested that it is a radial spoke specific band. The size of the band suggested that 
it is RSP3. To test this, the overlay was re-probed with anti-RSP3 antibody (Figure 4-
4A). Indeed anti-RSP3 decorated the band picked out by the overlay assay. Interestingly, 
the antibody also recognized a slightly smaller band corresponding to the hypo-
phosphorylated RSP3 (Qin et al., 2004). This suggests that Dpy-30 only binds to the 
phosphorylated form of RSP3. To differentiate if the bands revealed in the overlay is due 
to Dpy-30 and not due to the antibodies directly, a control blot was only probed with anti-
Dpy-30 and the secondary antibody only. As predicted, the control blot did not reveal 
RSP3. It remains to be determined whether Dpy-30 binds to RSP3’s AHD or AHR in the 
overlay assay.  
The overlay assay was also used to probe the bacterial extract that contains GST-
tagged AHD (RSP3269-316) and AHR (RSP396-180) separated on a SDS-PAGE gel. The 
Dpy-30 protein was shown to bind both AHs (Figure 4-4B). This further confirmed the 
cross-reactivity of AHR and Dpy-30. However, the antibodies that were raised against 
proteins purified from the bacterial extract generated undesirable backgrounds in the 
bacterial samples. This problem could be overcome by using purified protein samples or 
a different read out that does not depend on antibodies.  
Using the well characterized axonemal samples and defined bacterial extract, we 
showed that Dpy-30 is suitable as a ligand for the overlay assay. Similar to RII overlays, 
we envision that this Dpy-30 overlay is an amenable tool for testing various protein 
samples. The next step is to develop a high affinity AH as a blocker, analogous to Ht-31  
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Figure 4-3. Schematic depicting the Dpy-30 overlay procedure. 
 
The top panel depicts the overlay strategy and the bottom panel depicts the 
negative control blot that reveals Dpy-30 specific interactions. 
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y Y
 
Membrane Dpy-30 ligand  Dpy-30 Ab 2° Ab 
Predicted 
Result 
Overlay 
Anti Dpy-30 
blot 
:Dpy-30 Ab : 2° Ab : Dpy-30 
104 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
    
Figure 4-4. The Dpy-30 overlays. 
 
(A) Blots of the axonemes from WT and the spoke-less pf14 were probed for Dpy-30 
protein, anti-Dpy-30 and the secondary antibodies (left panel). A band of the size of 
RSP3 in WT axoneme and absent in pf14 was decorated (arrow). To test if the band is 
RSP3, the overlay blot was re-probed with α-RSP3 antibody (right panel). As 
expected, RSP3 antibody recognized two bands as RSP3 is a phosphoprotein. Note the 
upper band that was more phosphorylated (asterisk) was decorated in overlay. This 
suggests that phosphorylation of RSP3 promotes Dpy-30 binding. The control blot of 
axonemes was probed with anti-Dpy-30 and the secondary antibody without Dpy-30 
(middle panel). (B) The Dpy-30 overlay of the bacterial extract containing GST-AHD 
(RSP3269-316) (arrowhead, left panel). The control blot was probed with anti-Dpy-30 
and the secondary antibody only (middle panel). The bacterial extract GST- AHR 
(RSP396-180) that binds RIIa domain was decorated by Dpy-30 overlay. Thus Dpy-30 
protein cross-reacts with AHR in the overlay.  
 
A 
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for the RII overlay. Preferably, this AH could block the binding of Dpy-30 to AHD, but 
not AHR. 
 
4.2.2 Development of Quantitative Assays 
All three methods developed in this dissertation are suitable for the discovery of new 
Dpy-30-domain anchoring proteins. Each method has its own advantages and 
disadvantages. The common result is that Dpy-30 cross-recognizes AHR. However, the 
RIIa domain does not seem to recognize AHD. The deeper pocket of dimeric Dpy-30 may 
associate with AH with less stringency. The common limitation for these three methods 
mentioned above is that they are excellent for qualitative studies but cannot reveal 
quantitative data. They show either a positive or negative interaction but cannot 
differentiate the affinity of the AHs for Dpy-30. It is critical to develop a quantitative 
assay that could quantify the affinity of the AH-D/D interactions and identify a high 
affinity AH that would serve as a blocker for overlay and other studies. 
The high affinity peptide blockers for Dpy-30 are analogous to Ht-31 for RII. This 
peptide would act as a competitive inhibitor that disrupts proteins interacting with Dpy-
30. We postulate that the AHD in RSP3 binds Dpy-30 with a stronger affinity than the 
AHD in Ash2, because the radial spoke complex is an extraordinarily stable complex that 
can resist upto 0.6 M potassium iodide.  
 
4.2.2.1 GFP as a Reporter for a 96-Well Plate Assay 
For high throughput assays of Dpy-30-binding sequences, one way is to immobilize Dpy-
30 directly to the wells or indirectly through antibodies (Figure 4-5A). Then the wells can 
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be incubated with AHD tagged to a polypeptide that will aid the read out, like GFP.  For 
demonstration, the AHD from Ash2 was fused to GFP; this fusion protein can bind to 
Dpy-30 in the native gel (Figure 4-2). 
The purified GFP-AHD was first quantified by Bradford protein assay. To test if 
GFP releases enough fluorescence to be a sensitive reporter, different amounts of GFP-
AHD was added into each well and the light emitted after excitation was measured with a 
fluorescence microplate reader. The GFP was excited at 480-nm and the emission was 
measured at 510 nm (Figure 4-5B). The relative light intensity was plotted against the 
amount of the total GFP-AHD added. Unfortunately, 5-10 µg of GFP-AHD is necessary to 
obtain a reliable signal above the threshold level. Amounts less than that resulted in 
negative readouts or a high signal to noise ratio. Thus GFP-based assay is at least 1000 
fold less sensitive than ELISA that can detect less than 5 ng of molecules (Dixit et al., 
2010). Thus although the yield of recombinant GFP-AHD is high and the readout is very 
convenient, the fluorescence emitted per GFP is insufficient for a sensitive assay.   
Several parameters need to be established for a quantitative 96 well assay. One is 
to use different reporter systems, such as anti-GFP and chemiluminescence; or luciferase 
and luminescence. The former requires two steps of antibody incubations, while the latter  
allows direct measurement. However, the reagents for the luciferase assay are more 
expensive and have a shorter life span. In addition different types of 96 well plates need 
to be tested. Currently, only the high absorbance plate was tested. The preliminary data 
for ELISA revealed undesirably high signal to noise ratios. It may be necessary to test 
different types of 96 well plates for each output. 
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Figure 4-5. Developing Quantitative assays to test the affinity of Dpy-30 binding 
peptides. 
 
(A) Schematic depicting the fluorescence based quantitative assay to measure the 
affinity of Dpy-30-binding peptides. (B) The light emitted from the bound GFP- 
tagged-Ash2 AHD. FU: Fluorescence Unit. 
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 4.2.3 Screening Non-Peptide Blockers for Dpy-30 
High affinity blockers, like Ht-31, play a crucial role in RII overlays that identify AKAPs 
based on the AHR-RIIa interaction. However RII also interacts with proteins through un- 
determined interactions. Thus, in order to identify proteins that bind RII in an AKAP 
specific manner, high affinity blockers like Ht-31 are employed. Proteins are recognized 
as AKAPs if their interaction with RII is competitively blocked by Ht-31. Thus, a high 
affinity AH is instrumental to determine the specificity of the interactions in vitro.  Aside 
from overlays, the high affinity AHs and its membrane-permeable variants have been 
widely used for functional perturbations in various studies. Recently, small organic 
compounds were found to block the AKAP-RII interaction in ways similar or distinct 
from Ht-31 (Klussmann et al., 2006; Christian et al., 2011). Although the specificity of 
these compounds remain to be assessed, both peptide and non-peptide blockers could be 
potentially useful for perturbing the Dpy-30 and AHD interaction. 
 
4.2.3.1 Screening Chemical Blockers with Native PAGE 
The Dpy-30 and AHD interaction discovered in this thesis was used to test the feasibility 
of screening chemical inhibitors. This is a collaborative effort with the lab of Dr. Daniel 
Sem in the Department of Chemistry at Marquette University. An in-silico analysis using 
the AutoDock software was first conducted to align the crystal structure of the dimeric 
Dpy-30 domain with 10,000 compounds in a chemical library.  
Ten compounds that could best fit in the binding cavity of the dimeric Dpy-30 
domain were identified. The effects of these compounds in perturbing the association 
between Dpy-30 and an AHD was revealed by native gel and pull-down assays (Figure 4-
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4 and 4-5). GFP-Ash2-AHD was used in this assay, since if the assay is successful, the 
compound could be used to perturb the interaction of Dpy-30 and Ash2 in histone 
methyltransferase complex. 
An aliquot of 2 µg of Dpy-30 protein was incubated with 25 µM compound for 1 
hour at room temperature. Subsequently, GFP-Ash2-AHD was added into the mixture. 
The reaction mixture was then fractionated on a native gel and revealed by Coomassie 
stain (Figure 4-6). If a compound blocks the interaction between Dpy-30 and GFP-AHD, 
these two molecules will migrate as individual molecules in the native gel rather than a 
complex. Complex formation was assessed based on the appearance of new bands in the 
combined sample (Figure 4-6) and the reduced intensity of individual molecules. A 
sample without chemical compounds served as the negative control. The results showed 
that the predicted AHD from Ash2 binds to Dpy-30 in the presence of all the compounds. 
Thus none of the candidate compounds identified by the in-silico analysis were able to 
compete with AHD in Dpy-30 binding.  
Despite the negative result, this simple assay in theory could be used to identify 
high affinity compounds or AH peptides. However, this assay has several drawbacks. The 
number of samples that can be tested in each gel limits the number of compounds that can 
be screened. Thus this method could be used after candidate compounds are identified but 
not for a high-throughput assay. A larger chemical library with compounds of more 
diverse chemical properties than the current one may provide more candidates. Secondly, 
the Coomassie-stained output is not sensitive and thus a large quantity of compound is 
required for the assay. In addition, the first generation compounds may not have enough  
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Figure 4-6. Screening a library of compounds using the native gel assay. 
 
His-tagged Dpy-30 purified from bacteria was incubated with different compounds. 
Purified Ash-2 was subsequently added to the mixture and fractionated on a native gel. 
A mixture that did not contain any compounds served as the negative control. The 
numbers depict the different compounds. The arrow represents the Dpy-30 tetramer, 
the arrowhead represents the complex of Ash-2 and Dpy-30. 
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affinity for competition, if the affinity of Ash2-AHD for Dpy-30 is high. The dissociation 
constant, Kd of Ash2 and Dpy-30 is about 100 nM (Patel et al., 2009). 
4.2.3.2 Screening Chemical Blockers with Co-Purification 
The compounds were also assessed by co-purification of His-tagged Dpy-30 and GST-
AHR (RSP396-180) (Figure 4-7). AHR, instead of AHD, was chosen because AHR may have 
lower affinity for Dpy-30 and the interaction could be more easily blocked by chemical 
compounds. If a compound could block the interaction, GST-AHR will not be co-purified 
with His-tagged Dpy-30 protein by Ni-NTA.    
10 more compounds identified by in-silico analyses were tested with this method. 
Aliquots of His-tagged Dpy-30 protein pulled down by Ni-NTA was incubated with 50 
µM candidate compounds for 1 hour at room temperature. Subsequently, GST-AHR 
(RSP396-180) was added into the mixture. After one-hour incubation, the mixture was 
subjected to Ni-NTA and the flow through was collected. The samples of the input and 
the flow through were fractionated on an SDS PAGE gel and revealed by Coomassie 
stain (Figure 4-7). If the compound was able to perturb Dpy-30-AH interaction, the RSP3 
peptide in the flow through would be higher than that in the control without any 
compounds. 
The results revealed that the amount of unbound RSP3 peptide did not differ significantly 
between the experimental and the control sample (Figure 4-7). Although none of the 
compounds could serve as competitive inhibitors, this method is feasible and rather 
simple like the native gel assay. However, both methods suffer from the same limitation 
in sensitivity, qualitative results and the throughput levels. It also requires additional 
steps in pull-down and the amount of Ni-NTA matrix added to each reaction can vary 
112 
 
 
 
Structure Assigned 
Name 
Chemical Name 
 
3027 (b) 3-[(dimethylamino)methyl]-1,3-
benzoxazol-2(3H)-one 
 
10173 (d) 3-Phenylproline 
 
1059 (f) 3-Cyanobenzoate 
 1830 (g) 1H-benzimidazol-2-
ylmethanaminium 
 2027 (h) 2-[(furan-2-
ylcarbonyl)amino]ethanaminium 
 
2908 (c) 5-(4-fluorophenyl)tetrazol-1-ide 
 9606 (e) 2-(piperidin-1-ylmethyl)phenol 
 
4046 (i) 3-phenyl-N-(2H-tetrazol-5-
yl)propanamide 
 
8075 (a) 1-phenyl-1,2-dihydro-5H-
tetrazole-5-thione 
 
 
 
 
 
 
 
 
 
 
Table 4-1. List of Chemical compounds 
 
The table showcases the structures and chemical names of the 
organic compounds used in the screening. The number in the 
assigned name column was designated by Dr. Sem’s lab and the 
letters correspond to those used in Fig 4-7. 
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Figure 4-7. Pull-down assay for screening organic compounds. 
 
Purified His-tagged Dpy-30 was incubated with different compounds first and the Dpy-
30-binding peptide, RSP396-180. The mixture (pre) and the flow through (post) from Ni-
NTA affinity chromatography were assessed by SDS-PAGE to test if any compound 
inhibited the interaction of Dpy-30 and RSP396-180. The control lanes are samples 
without any compounds. The letters depict the different compounds that were tried. 
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easily during experimentation. 
4.3 Discussion 
The preliminary studies described in this chapter explored the interactions between the 
Dpy-30 domain and its binding AHs in the existing anchoring proteins. The reagents and 
assays developed here demonstrate the direction for future studies. The improved tools 
will be invaluable for studying the emerging proteins in the RIIa clan and the molecules 
that anchor these novel proteins.     
Taking advantage of the existing reagents, the various assays revealed the cross-
reactivity of the Dpy-30 domain and AHR that is supposed to bind the RIIa domain. This 
is not particularly surprising given the similar secondary and tertiary structures of these 
domains. However, this finding leads to the question of how AHR and AHD in RSP3 bind 
to the respective RIIa- and Dpy-30 domain containing RSPs. In addition, how do the 
numerous anchoring molecules with various AHs in the cell body interact with only the 
right partners in the cell body? Several possibilities are proposed and will be dealt with in 
Chapter 5.     
The preliminary data revealed the reagents and methods that could be used for the 
study of Dpy-30 domain and its interactions with various anchoring proteins. Each assay 
has advantages and drawbacks. Most of them are feasible but need to be optimized. One 
important contribution of this study is the use of Dpy-30 as a ligand in the overlay. As 
Dpy-30 exhibits cross-reactivity for AHR that binds the RIIa domain, it is possible that 
the Dpy-30 overlay can replace RII overlay for a broad spectrum screening of anchoring 
proteins. To further differentiate the RIIa binding proteins, a duplicate blot could be 
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processed for RII overlays with and without Ht-31 blockers. The bands that are only 
recognized by Dpy-30 could be the anchoring proteins for Dpy-30 domains. Those 
recognized by RII and Dpy-30 could be the anchoring proteins with AHR or with both 
AHR and AHD, like RSP3. It is also desirable to modify the AHD into a specific peptide 
blocker that competitively inhibits binding with Dpy-30 domain while not affecting the 
binding with RIIa domain.  
To develop high affinity AH as blockers, it is preferable to develop quantitative 
assays to determine the affinity of the existing AHD for the Dpy-30 domain. The AHD 
with the highest affinity can be used to devise additional peptides with even higher 
affinity. If the quantitative assay is sensitive and high throughput, it could be used in the 
screening of chemical libraries. Other strategies for developing peptide variants could be 
considered. For example, peptide arrays have been commonly used in the development of 
high affinity binding peptides. A spectrum of peptides, in which each residue is replaced 
by every possible a.a., are spot synthesized into a chip-like matrix. The matrix could be 
probed with ligands, like RII or Dpy-30 in the overlay assay. While some peptides lose 
the ability to bind the ligand, some others have higher affinities. This unbiased screening 
strategy led to the discovery of several AHs that bind RII with affinity 5 -10 fold higher 
than physiological AKAPs (Alto et al., 2003; Burns-Hamuro et al., 2003; Gold et al., 
2006). These super AHs can also be further modified to be specific for RII or RI. In 
addition, this exhaustive technique also can reveal considerable information about the 
role of each amino acid in the AH. This peptide array is worth considering for developing 
tools to study the Dpy-30 domain.   
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Chapter 5: Discussion 
 
 
This dissertation set out to discover how an axonemal complex that controls flagellar 
motility accommodates two pairs of proteins that contain similar RIIa clan domains. The 
results revealed that the two types of RIIa clan domains, RIIa and Dpy-30, dock to two 
similar AHs in a dimeric protein, RSP3. These conclusions support a new model that can 
explain the assembly and function of the RS. They also suggest that the AH and D/D 
domains constitute a localization mechanism for a spectrum of effector mechanisms 
much broader than PKA. These findings not only question the existing concepts of these 
molecular modules but also raise intriguing queries that remain to be investigated. The 
tools developed in this dissertation could be used to make headway into future studies. 
 
5.1 A New RS Model 
Both in vivo and in vitro evidence support a model that the RSP3 dimer extends 
throughout the spokestalk with two discrete regions for anchoring the two types of D/D 
domains in four RSPs. A region near Coil 2 anchors the Dpy-30 domain present in RSP2 
and RSP23. The helices downstream to the binding region in both RSP2 and RSP3 may 
form coiled coils with each other and with the head components. As for RSP23, the Dpy-
30 domain could tether the associated NDK activity to the RS complex (Patel-King et al., 
2004). Finally, the spoke-specific HSP40 (RSP16) is added to this region (Yang et al., 
2008). Through these multiple interactions, the head, neck and stalk are linked together as 
a single unit that can couple the CP and outer doublets at a high frequency. 
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Figure 5-1. The new RS model. 
 
Schematic depicting the topology of the radial spoke complex. RSP3 dimer of the 
conserved region forms the stalk scaffold (black and grey lines). The N terminus of 
RSP3 docks 5 LC8 molecules (pink ovals) (Gupta et al., unpublished). The AHR 
docks the RIIa-domain containing proteins, RSP7 (orange and red spheres) and 
RSP11 (yellow and mustard spheres). The binding of these proteins in turn tethers 
the associated effector mechanisms, the calcium binding motifs (green circles) of 
RSP7 and the armadillo (ARM) repeat protein (RSP8, light pink oval) which binds 
to RSP11 and the coil1 region in RSP3 and enhances the rigidity of the spoke stalk. 
The Dpy-30-domain containing proteins dock onto the downstream AHD. Both RSP2 
and RSP23 form part of the neck sub-complex and helps to link the spoke head and 
spoke stalk modules. CP, Central pair apparatus; NDK, Nucleoside Diphosphate 
Kinase domain; D, Dpy-30 domain; R, RIIa domain; ARM, ARMadillo repeat 
protein. 
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The RIIa domain of RSP11 docks onto the AHR in RSP3 while the short flanking 
sequence tethers the armadillo repeat protein, RSP8 to interact with the Coil 1 region in 
RSP3 directly or indirectly. We speculate that this may enhance the rigidity of the 
dimeric RSP3 core, since the mutants defective in RSP11 can swim but become 
paralyzed in the exhausted media (Yang and Yang, 2006). By the same token, RSP7’s 
RIIa domain docks to the same AHR in the other RSP3 monomer. Yet contrary to the 
constitutive function of RSP11, RSP7’s EF-hands are in position to allosterically 
modulate the stalk when calcium increases, in a way analogous to the cAMP-induced 
allosteric release of the PKA catalytic subunit.  
The various functions of these four RSPs are all docked through the D/D domains 
to the two AHs in RSP3. As RSP3 N-terminus associates with the microtubule outer 
doublets in the axonemes (Diener et al., 1993) while the C-terminus is involved in the 
spokehead assembly, the dimeric RSP3 clearly is a bona fide core scaffold of the entire 
complex. The RSP3 sequence also supports this new RS model. The spoke stalk length 
has been proposed to be around 38-41 nm by studies of axonemes prepared and 
visualized by different methods (Nicastro et al., 2005; Yang et al., 2001). Although 
Chlamydomonas RSP3 is 516 a.a. in length; sequence homology and functional studies 
have shown that the C terminal region is dispensable (Diener et al., 1993). This study 
further defined that 1-316 a.a region of RSP3 is the smallest essential region.  
The N terminus of this essential region contains 5 LC8 binding sites and has been 
shown to bind LC8, a small ubiquitous molecule that functions as a dimer (Gupta et al., 
unpublished). Five LC8 molecules span a distance of 20 nm (Stelter et al., 2007). The rest 
of the conserved region is mainly coiled coil in nature (Fig 3-1 B). Considering the rise 
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per residue along a straight α-helix is 0.15nm (Lim et al., 1951), this region between 161 
and 316 a.a would span a distance of 23 nm, bringing up the entire spoke stalk length to 
~43 nm which is very close to the current estimate. Thus RSP3 can span the spoke stalk 
distance, supporting this complex that regulates oscillatory beating mechanically and 
chemically. 
 
5.2 Versatility of the AH-D/D Localization System 
The interactions of AHR in RSP3 with RII in vitro (Gaillard et al., 2001) but with non-
PKA RSP7 and RSP11 in vivo further confirms the predicted functional equivalence of 
these domains (Yang and Yang, 2006; Newell et al., 2008). This equivalence is also true 
for human Dpy-30 protein in histone methyltransferase complex. Dpy-30 binds to Ash2 
in the histone methyltransferase complex in vivo (Roguev et al., 2001; Dehe et al., 2006) 
but recognizes RSP3’s AHD that binds the Dpy-30 domain in RSP2 and RSP23 in the RS 
complex.  
Contrary to the conserved anchoring and docking domains, the effector 
mechanisms may not be evolutionarily conserved. The RIIa clan members are drastically 
diverged. The orthologues of these four members in Chlamydomonas RS are not evident 
in other organisms even though RSP3 orthologues, including the anchoring AHs, are 
conserved. The orthologous RIIa clan members contain the RIIa clan domains but differ 
in the nature of the associated flanking sequence. The conserved localization mechanism 
but divergent effector mechanisms may be an evolutionary scheme to tailor the motility 
control to suit the special needs of individual cell types in different environments. For 
instance, calcium and cyclic nucleotides induce motility changes in virtually all motile 
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cilia and flagella. However each cell type responds differently to these second 
messengers (Smith and Yang, 2004). Perhaps for different organisms, the second 
messengers act on the diverged RIIa clan members, including RI or RII, in the RS to 
induce different motility changes. As motile cilia and flagella are critical for the survival 
of individual species, these diverged effector mechanisms may have evolved 
independently and those that give individual species advantages in their respective 
environment are retained. Thus AHs and D/D domains constitute a versatile system to 
anchor various effector mechanisms beyond PKA. 
  
5.3 The AH Molecular Scaffolds 
This study shows that, although D/D domains can anchor various effector mechanisms, 
the molecules with AHs may largely serve as scaffolds of molecular complexes. AKAPs 
are signal transduction scaffolds that anchor multiple molecular switches and PKA via 
the AH-D/D interaction (Wong and Scott, 2004). This dissertation shows that RSP3, once 
known as AKAP, is indeed a signal transduction scaffold as it anchors effector 
mechanisms like RSP7’s EF hands that transduce calcium signals. However, the term 
signal transduction scaffold falls short of depicting the essence of RSP3 which is to 
support the entire RS complex structurally. Furthermore, some effector mechanisms 
anchored to RSP3’s AHs are for the assembly or constitutive enhancement of this 
structural complex. Hence RSP3 is both a structural and signal transduction scaffold.  
Recognition that proteins with AHs could serve as structural scaffolds is 
important to understand the molecular complexes with AH-containing anchoring 
molecules. The usage of AH-D/D interaction in building up a structural scaffold may not 
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be unique to RSP3, the RS or flagella. The same could be true for Ash2, a component in 
the Set 1-like histone methyl transferase complex. Ash2 interacts with Dpy-30 in the core 
complex in various Set1-like histone methyltransferase complexes (Patel et al., 2009; 
Cho et al., 2007). Both molecules are important for the enzymatic activity, albeit in 
different ways (Patel et al., 2010). Ash2 is vital for the enzymatic activity while Dpy-30 
is not. Yet Dpy-30 affects the H3K4me3 level across the entire embryonic stem cell 
genome (Jiang et al., 2011). Aside from Dpy-30, Ash2 also associates with RbBP5, a 
WD-repeat protein subunit in the core complex (Patel et al., 2009). It is possible that 
Ash2 serves as a structural scaffold of this complex that transfers methyl groups.  
The other examples are BIG1 and BIG2, the paralogous guanine nucleotide 
exchange factors in the trans-Golgi network. These two large molecules interact with 
each other. BIG2 also contains three AHs that can interact with RI or RII in vitro (Li et 
al., 2003), whereas BIG1 contains an AH that anchors Dpy-30 in vivo (Ishizaki et al., 
2006; Xia et al., 2010). In addition, each of them also associates with other molecules 
that mediate critical functions related to membrane trafficking. This heterodimer, like the 
RSP3 homodimer, may form a hybrid scaffold for structural and signaling purposes. 
Thus, it is possible that the molecules that utilize AH for anchoring a variety of 
the RIIa clan molecules with D/D domains are molecular scaffolds in general. Some are 
strictly for forming the structural backbone of molecular complexes; some anchor 
molecular switches for signal transduction and the others have combined features. The 
term AKAP is appropriate for those molecules that actually anchor PKA yet misleading 
for those that do not like RSP3. Therefore, we propose to use D/D-domain Anchoring 
Proteins (DAPs) to designate the molecules that utilize AHs to anchor myriads of 
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functions tethered through a D/D domain. It would be apt to refer to AKAPs as a sub-
family of DAPs that specifically anchor PKA in vivo.  
 
5.4 The Conservation and Divergence of the AH-D/D System 
We expected that the sequences for anchoring the RIIa and Dpy-30 domains are specific 
and significantly different for three reasons. These two domains are present in the same 
complex. Furthermore, the residues and the length of helices in the two domains are 
diverged enough to be classified into two families. Lastly, the N-termini in these two 
domains that contact binding peptides are distinct (Wang et al., 2009). Yet the AHR for 
the RIIa domain and the AHD for Dpy-30 domain are similar in their sequence pattern 
and binding principle, and are present in the same molecule, RSP3. And interestingly, the 
similarity is high enough that AHR and Dpy-30 bind in the in-vitro setting. 
The cross reactivity indicates that RIIa and Dpy-30 domains are more similar than 
expected. This notion prompted us look into the RIIa variant—the RIIa domain from the 
RI subunit of PKA. Interestingly, the N-terminus of Dpy-30 and RI’s RIIa domain are 
both helical (Banky et al., 2003; Wang et al., 2009; Sarma et al., 2010). In contrast to the 
β-strand in RII’s RIIa, the N-terminus of both RI’s RIIa and Dpy-30 forms an α-helix 
that contributes to a deeper pocket for the AH (Banky et al., 2003; Sarma et al., 2010). 
Their structural alignment appears equal to, if not greater than, the alignment of Dpy-30 
and RII’s RIIa domain (Wang et al., 2009). Thus, although the N-terminus of the RIIa 
clan domains is critical for binding to an AH, it is insufficient to drastically change the 
interacting peptide sequences. Despite the classification of the RIIa clan into two 
families, the principle of molecular interactions for the two D/D domains is identical. The 
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strong resemblance is resonated by the cross-recognition between the Dpy-30 domain and 
the AHR. 
 
5.5 Selective Cross-Reactivity of the AH and D/D Domain 
The similarities between both the AH and D/D domains is reflected in the in vitro 
recognition of the AHR by Dpy-30 as well as RIIa from RSP7 and RSP11. Yet, AHD 
binds to Dpy-30 alone and not the RIIa from RSP7 in either the pull down or the overlay 
assay (Gaillard et al., 2001).  
However, it is premature to generalize that only AHR and Dpy-30 have cross 
reactivity or this cross reactivity is due to unique structural features. It has been 
demonstrated that some AHs are mono-specific, binding to either RI or RII but not both 
(Angelo and Rubin, 1998; Hirsch et al., 1992), whereas certain AHs, from dual-specific 
AKAPs, recognize both RI and RII (Huang et al., 1997; Wang et al., 2009; Li et al., 
2003). In this regard, the AHR in RSP3 is a dual-specific AH, whereas AHD appears 
mono-specific to Dpy-30. Sequence comparisons of the representative AHs did not reveal 
any consensus that will distinguish mono-specific or dual-specific AHs. The cross 
reactivity may be more about the specific amino acids in individual AHs than the D/D 
domain they bind to. Conversely, given the structural similarity between RI and Dpy-30, 
it will be interesting to test if AHD, in RSP3, Ash2 or other molecules, can recognize the 
RIIa domain from RI. 
 The dual-specific AHs in AKAPs bind PKA in both the RI or RII subunits. 
However, the cross reactivity of AHR in vitro with Dpy-30 creates interesting dilemmas 
in vivo —why does cross recognition not occur in the RS or in the cell body? If this 
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occurred, the spokehead could potentially form at the middle of the stalk, rather than at 
the expected distal end. Likewise, Dpy-30 is not expected to dock to AKAPs while PKA 
is not known to be in the histone methyltransferase complex.  
One may assume that there are determinants for the specificity. As most AHs tend 
to be specific for RI or RII, perhaps the sequences in AHR and AHD are distinctive 
enough to localize the respective effector mechanisms precisely. Or the difference in 
affinity is sufficient to sort out the specificity that is observed in vivo. In general, the 
affinity of the AHs for RI is lower than that for RII (Herberg et al., 2000). Thus RI is 
often more evenly distributed throughout the cell body while RII is restricted to particular 
loci (Kinderman et al., 2006). The third possibility is the most interesting-- the specificity 
of certain AHs and the D/D are not as stringent as the connotations of these domains. In 
fact the specificity could be facilitated by other molecular cues, like the flanking 
sequences. It has been demonstrated that in dual-specific AKAPs, a sequence outside of 
AHR contributes to RI recognition (Jarnaess et al., 2008). Similarly, the sequences 
flanking the AHD in RSP3 and the Dpy-30 domain in RSP2 (Gopal et al., unpublished) 
may be involved in interactions with each other and molecules in the vicinity. If this is 
true, the AH and D/D domain may be more about docking and less about targeting. While 
all the eyes are on the AH and D/D domains, the flanking sequences may be equally 
informative. 
 
5.6 Tools for the DAPs 
The breadth and similarity of the AH and D/D domains presents ample opportunities yet 
also poses conundrums for research. The AH-RIIa interaction has been exploited for 
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discovering various AH-containing proteins that were recognized by RII. Two key tools 
are RII and high-affinity AHs. RII is used as a ligand to identify molecules with AHs 
(Lohmann et al., 1984). However, molecules could bind to RII ligand via sequences 
irrelevant to the AH. Thus only the interactions that could be perturbed by the high 
affinity AHs that originated from AKAPs are considered genuine (Carr et al., 1992). 
These two key tools led to the discovery of many AKAPs. Similar tools suitable for the 
Dpy-30 domain could potentially hasten the discoveries in the Dpy-30 field.  
This study has demonstrated that Dpy-30 can serve as a ligand in pulldown or in 
an overlay assay. The axonemal bands revealed by Dpy-30 overlay are similar, if not 
identical, to that obtained by the RII overlay (Gaillard et al., 2001). This shows that AHD 
in various molecules, not just in Ash2, can bind Dpy-30 in vitro and that Dpy-30 could be 
used to discover other proteins that have an AHD, just like RII was used for the discovery 
of AKAPs.    
From a structural perspective, the ability to utilize Dpy-30 as a ligand is 
interesting. RII exists as a homodimer, with the binding pocket exposed in solution. 
However, purified Dpy-30 forms tetramers (Dong et al., 2005). The AH-binding pocket is 
almost concealed in the tetramer (Wang et al., 2009). The results of the overlay assay and 
the pulldown suggest that the pocket is still accessible to the AH. Also in the native gel, 
Dpy-30 shifts in the opposite direction when it complexes with monomeric or dimeric 
carrier-AHs. It is possible that dimeric AH may further pry open the Dpy-30 tetramers 
into dimers.   
Importantly, AHD in RSP3 cannot be recognized by RII (Gaillard et al., 2001) but 
can be recognized by Dpy-30. Conversely, Dpy-30 recognizes AHD as well as AHR. The 
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cross reactivity of Dpy-30 may be exploited in situations where using RII is not suitable.  
In theory, Dpy-30 overlay can potentially be used as a general screen to reveal all  
molecules with AHD or AHR, namely all DAPs. To sort out molecules that contain AHD 
or AHR, two additional strategies can be employed. One is to develop a high affinity AH 
for Dpy-30 domain. This AH, analogous to Ht-31, should be able to abolish the non-
specific interactions. It will be of interest to see if it is possible to develop AHs that 
specifically disrupt the interaction of Dpy-30 with either AHD or AHR. For this purpose, 
the existing reagents and methods could be developed into sensitive quantitative 96-well 
assays either directly or through ELISA. Other high throughput systems, like peptide scan 
on spot arrays can also aid in the identification of new high affinity AHs (Alto et al., 
2003, Burns-Hamuro et al., 2003). Once identified, the assay could be used to measure 
the affinity of AH variants.  
Aside from the overlay assay, the AHD with high affinity and high specificity for 
Dpy-30 could be used in other perturbation assays, both in vitro as well as in vivo. Note 
high affinity AHR, like membrane permeable variants of Ht-31, have been widely used to 
study the significance of PKA anchoring in cell cultures or organ cultures. The effect is 
not identical to PKA inhibitors (Vijayaraghavan et al., 1997). This could be due to the 
inherent differences between the roles of PKA and AKAPs. It is also possible that some 
of the AHR may disturb the interactions of Dpy-30. Likewise, it is foreseeable that a high-
affinity AHD may modulate H3K4 methylation but in a slightly different way from Dpy-
30 knockdown or inhibitors of methyltransferases. Taken together, this dissertation will 
hasten the expansion of the field of protein anchoring and docking. Modifications of the 
new tools and assays will take the AH-D/D field to a robust future.  
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